Elaine Jaffe

Q: What Schools Are Affiliated With Elaine Jaffe

Elaine Jaffe is affiliated with the following schools: University of Cologne, University of Oxford, Weill Cornell Medicine, Nagoya University, University of Washington, University of Pittsburgh, Columbia University, Technical University of Munich, Tianjin Medical University, Massachusetts General Hospital, University of Bologna, University of Pennsylvania

Elaine Jaffe's AcademicInfluence.com Rankings

Elaine Jaffe

Biology

#927

World Rank

#1619

Historical Rank

#498

USA Rank

Pathology

World Rank

#17

Historical Rank

USA Rank

biology Degrees

Download Badge

Biology

Elaine Jaffe's Degrees

Doctorate Medicine University of Pennsylvania

Why Is Elaine Jaffe Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Elaine Sarkin Jaffe is a senior National Cancer Institute investigator at the National Institutes of Health most well known for her contribution to hematopathology. She completed her medical education at Cornell University and the University of Pennsylvania, receiving her M.D. degree from University of Pennsylvania in 1969. After an internship at Georgetown University she joined NCI as a resident in anatomic pathology, and has been a senior investigator since 1974, focusing on the classification and definition of lymphomas. Jaffe's early work helped to provide a deeper understanding of the origin of lymphomas, especially follicular lymphoma. Her team notably elucidated the difference between T cell and B cell lymphomas.

(See a Problem?)

Elaine Jaffe's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. (1994) (6264)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms. (2016) (5445)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. (2004) (3681)
WHO-EORTC classification for cutaneous lymphomas. (2005) (3669)
The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. (1999) (3234)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. (2002) (2370)
Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (2003) (2277)
Involvement of the bcl-2 gene in human follicular lymphoma. (1985) (1884)
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. (2011) (1782)
Stromal gene signatures in large-B-cell lymphomas. (2008) (1611)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma (2010) (1436)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. (2004) (1410)
Oncogenically active MYD88 mutations in human lymphoma (2011) (1341)
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. (1999) (1331)
Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. (2010) (1140)
Genetics and Pathogenesis of Diffuse Large B‐Cell Lymphoma (2018) (1081)
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma (2003) (1074)
The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. (1985) (1028)
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways (2008) (971)
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. (2003) (948)
Molecular diagnosis of Burkitt's lymphoma. (2006) (871)
Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (2012) (844)
Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma (2008) (828)
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics (2012) (766)
Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. (1996) (723)
Spectrum of AIDS-associated malignant disorders (1998) (721)
Contemporary classification of histiocytic disorders (1997) (713)
The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. (2019) (677)
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma (2017) (677)
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. (2009) (668)
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. (1999) (632)
A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy (2009) (625)
Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms. (1983) (614)
ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. (2008) (612)
Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma (1999) (609)
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. (2009) (587)
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases (2002) (586)
Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. (2009) (531)
Mantle Cell Lymphoma A Proposal for Unification of Morphologic, Immunologic, and Molecular Data (1992) (516)
Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue. (2014) (510)
Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. (1996) (483)
EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression (2010) (466)
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. (2001) (452)
Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. (1999) (441)
Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11 ; 14) chromosome translocation (1985) (439)
Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. (2002) (436)
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. (2013) (428)
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma. (2011) (426)
Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies. (2000) (425)
T‐Cell Lymphoma Involving Subcutaneous Tissue: A Clinicopathologic Entity Commonly Associated with Hemophagocytic Syndrome (1991) (415)
Twenty years of MOPP therapy for Hodgkin's disease. (1986) (409)
Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas. (1980) (407)
The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 (2000) (404)
Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. (1983) (404)
p53 mutation is associated with progression in follicular lymphomas. (1993) (401)
Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. (2005) (400)
Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. (2010) (396)
Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. (1983) (393)
Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow (1988) (390)
Diffuse Large B-cell Lymphomas With Plasmablastic Differentiation Represent a Heterogeneous Group of Disease Entities (2004) (387)
The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. (2015) (386)
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. (2012) (386)
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. (2006) (385)
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. (1997) (380)
Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. (2008) (367)
Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure. (1992) (364)
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes. (2014) (363)
Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. (1997) (362)
Nodular lymphoma--evidence for origin from follicular B lymphocytes. (1974) (358)
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. (2011) (358)
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype (2009) (356)
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation. (2009) (347)
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. (2000) (346)
Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. (2003) (346)
Bethesda proposals for classification of lymphoid neoplasms in mice. (2002) (344)
Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. (1999) (342)
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma. (2017) (341)
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. (2005) (335)
FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome (1998) (330)
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment. (1988) (329)
Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms. (2000) (328)
Burkitt's lymphoma: a single disease with multiple variants. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. (1999) (324)
THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES REPORT OF THE CLINICAL ADVISORY COMMITTEE MEETING (2000) (322)
bcl-1, t(11;14), and mantle cell-derived lymphomas. (1991) (320)
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. (2017) (320)
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. (2005) (319)
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. (2015) (317)
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. (2004) (317)
Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. (1996) (314)
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. (2000) (314)
Frequent presence of the Epstein-Barr virus in inflammatory pseudotumor. (1995) (310)
p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. (1996) (307)
Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. (1992) (307)
A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. (1992) (300)
Malignant lymphomas--a conceptual understanding of morphologic diversity. A review. (1979) (295)
Non‐Hodgkin's lymphoma (1995) (294)
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy. (2002) (294)
Enteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project. (2011) (293)
Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. (1988) (290)
Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. (2013) (288)
Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. (2011) (287)
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers. (2008) (286)
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. (1999) (285)
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. (2004) (284)
Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. (2008) (279)
Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. (1990) (277)
Cooperative epigenetic modulation by cancer amplicon genes. (2010) (273)
Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. (2006) (273)
Mediastinal Gray Zone Lymphoma: The Missing Link Between Classic Hodgkin's Lymphoma and Mediastinal Large B-Cell Lymphoma (2005) (272)
Low-intensity therapy in adults with Burkitt's lymphoma. (2013) (272)
Classification of natural killer (NK) cell and NK-like T-cell malignancies. (1996) (270)
Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. (1983) (268)
Extranodal Histiocytic Sarcoma: Clinicopathologic Analysis of 14 Cases of a Rare Epithelioid Malignancy (2004) (268)
Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma. (2003) (263)
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma (1994) (261)
Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. (2009) (260)
European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. (2000) (254)
MYC rearrangements in histologically progressed follicular lymphomas. (1992) (253)
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. (1995) (249)
An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. (1984) (248)
Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers. (1976) (246)
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. (2007) (243)
Detection of human herpesvirus 6 in tissues involved by sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease). (1992) (243)
Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. (1994) (242)
IG/MYC Rearrangements are the Main Cytogenetic Alteration in Plasmablastic Lymphomas (2010) (242)
EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. (1993) (240)
Relationship of p53, bcl-2, and tumor proliferation to clinical drug resistance in non-Hodgkin's lymphomas. (1997) (238)
Fulminant EBV+ T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome (2000) (238)
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma. (2011) (235)
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. (2011) (233)
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. (2006) (231)
A Multiprotein Supercomplex Controlling Oncogenic Signaling in Lymphoma (2018) (229)
Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease. (1984) (227)
Loss of signaling via Gα13 in germinal center B cell-derived lymphoma (2014) (226)
In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. (2002) (225)
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. (1998) (219)
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. (1991) (217)
EBV-positive large B-cell lymphomas in young patients: a nodal lymphoma with evidence for a tolerogenic immune environment. (2015) (214)
Lymphocytic Lymphoma of Intermediate Differentiation: Morphologic and Immunophenotypic Spectrum and Clinical Correlations (1990) (212)
Pathological findings in human autoimmune lymphoproliferative syndrome. (1998) (210)
IgVH Mutational Status and Clonality Analysis of Richter's Transformation: Diffuse Large B-cell Lymphoma and Hodgkin Lymphoma in Association With B-cell Chronic Lymphocytic Leukemia (B-CLL) Represent 2 Different Pathways of Disease Evolution (2007) (207)
Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. (1996) (206)
Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. (1998) (205)
Pathologic and clinical spectrum of post-thymic T-cell malignancies. (1984) (200)
Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma (2007) (200)
Nasal Lymphomas in Peru: High Incidence of T-Cell Immunophenotype and Epstein-Barr Virus Infection (1993) (199)
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma (2007) (199)
Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. (1990) (197)
Association of the human type C retrovirus with a subset of adult T-cell cancers. (1983) (197)
Epidemiology of human T-cell leukemia/lymphoma virus. (1983) (197)
Phenotypic expression of Hodgkin's and Reed-Sternberg cells in Hodgkin's disease. (1985) (194)
The pathologic spectrum of adult T‐cell leukemia/lymphoma in the United States: Human T‐cell leukemia/lymphoma virus‐associated lymphoid malignancies (1984) (191)
Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. (1997) (189)
Anaplastic Large Cell Lymphoma: The Shifting Sands of Diagnostic Hematopathology (2001) (189)
Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. (2014) (187)
Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas. (2000) (187)
Parameters affecting the development of non-Hodgkin's lymphoma in patients with severe human immunodeficiency virus infection receiving antiretroviral therapy. (1993) (185)
Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. (2000) (184)
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. (2007) (183)
Malignant Lymphomas Involving the Ovary: A Clinicopathologic Analysis of 39 Cases (1993) (182)
Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. (1998) (182)
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. (2018) (179)
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations. (2007) (178)
Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study. (1995) (175)
The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. (1997) (171)
The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. (2010) (170)
BCL2 Predicts Survival in Germinal Center B-cell–like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab (2011) (170)
Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study. (2006) (169)
Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma). (1998) (166)
Series THE UPDATED WHO CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES The 2016 revision of the World Health Organization classi fi cation of lymphoid neoplasms (2016) (166)
The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee. (2022) (165)
Transformation of follicular lymphoma to diffuse large B‐cell lymphoma proceeds by distinct oncogenic mechanisms (2007) (165)
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma. (2013) (164)
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma. (2014) (162)
Immunologic aspects and pathology of the malignant lymphomas (1978) (162)
Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection. (1999) (159)
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior (2012) (159)
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial. (1991) (159)
Plasmacytoid Dendritic Cells: Physiologic Roles and Pathologic States (2009) (159)
CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. (1995) (157)
Mycosis fungoides and Sézary syndrome (2008) (157)
Plasmablastic lymphoma with MYC translocation: evidence for a common pathway in the generation of plasmablastic features (2010) (156)
Lymphocyte subsets in normal human lymphoid tissues. (1983) (155)
Inflammatory pseudotumor of the spleen (1984) (155)
The human T-cell leukemia-lymphoma virus in the southeastern United States. (1983) (155)
Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy. (1979) (152)
A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. (1996) (151)
Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection. (1999) (151)
Localization of Epstein‐Barr Viral Genomes in Angiocentric Immunoproliferative Lesions (1992) (151)
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma (2006) (150)
Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. (2013) (149)
Extranodal peripheral T-cell and NK-cell neoplasms. (1999) (148)
Clonally related Histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: A study of 7 cases (2011) (148)
NIH conference. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. (1984) (147)
Diversity of immunological phenotypes of lymphoblastic lymphoma. (1983) (147)
PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. (1994) (147)
Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management. (1988) (147)
DNA rearrangements in human follicular lymphoma can involve the 5' or the 3' region of the bcl-2 gene. (1987) (147)
Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. (2011) (146)
Primary nodal marginal zone lymphomas of splenic and MALT type. (1999) (146)
Leukemic reticuloendotheliosis: presence of a receptor for cytophilic antibody. (1974) (144)
Clonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphoma. (1987) (144)
The immunopathology of sequential tumor biopsies in patients treated with interleukin-2. Correlation of response with T-cell infiltration and HLA-DR expression. (1987) (144)
Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. (1999) (144)
Marginal Zone B-Cell Lymphoma in Children and Young Adults (2003) (143)
Angiocentric immunoproliferative lesions: a molecular analysis of eight cases. (1991) (143)
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Reed-Sternberg–Like Cells and Possible Transformation to Hodgkin's Disease: Mediation by Epstein-Barr Virus (1992) (142)
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. (2004) (142)
PTEN gene alterations in lymphoid neoplasms. (1998) (140)
The Genetic Basis of Hepatosplenic T-cell Lymphoma. (2017) (140)
γδ T-Cell Lymphoma of the Skin: A Clinical, Microscopic, and Molecular Study (2000) (140)
Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications (2010) (140)
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling. (2010) (139)
NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. (2011) (139)
Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. (1995) (138)
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens (2015) (137)
Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. (1998) (136)
Lymphocytic lymphoma of intermediate differentiation--mantle zone lymphoma: a distinct subtype of B-cell lymphoma. (1987) (135)
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. (2019) (135)
Histologic Features of Sinus Histiocytosis With Massive Lymphadenopathy in Patients With Autoimmune Lymphoproliferative Syndrome (2005) (135)
Analysis of T cell receptor-gamma gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products. Correlation with tumor-specific sequences. (1995) (134)
Receptors for Complement and Immunoglobulin on Human and Animal Lymphoid Cells (1973) (134)
Hodgkin lymphoma: an update on its biology with new insights into classification. (2009) (133)
Functional markers: a new perspective on malignant lymphomas. (1977) (132)
Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor. (1998) (131)
The clinical spectrum of Erdheim-Chester disease: an observational cohort study. (2017) (131)
Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas. (1977) (130)
Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. (1995) (128)
Primary low-grade B-cell lymphoma of the dura: a mucosa associated lymphoid tissue-type lymphoma. (1997) (128)
Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome. (2010) (128)
Peripheral T‐cell and NK‐cell lymphomas and their mimics; taking a step forward – report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology (2014) (127)
Sjögren's syndrome-like illness associated with the acquired immunodeficiency syndrome-related complex. (1987) (127)
Lymphoproliferative Lesions in Patients with Common Variable Immunodeficiency Syndrome (1992) (127)
Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy? (1988) (126)
Essential role of the linear ubiquitin chain assembly complex in lymphoma revealed by rare germline polymorphisms. (2014) (125)
Malignant lymphomas: current classification and new observations. (1975) (124)
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. (1989) (123)
Peripheral T-Cell Lymphoma with Aberrant Expression of CD79a and CD20: A Diagnostic Pitfall (2001) (121)
Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. (2019) (120)
Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas. (2007) (120)
Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. (1996) (120)
Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH. (2000) (120)
The human T-cell leukemia/lymphoma virus, lymphoma, lytic bone lesions, and hypercalcemia. (1983) (119)
Epstein-Barr virus-positive primary gastrointestinal Hodgkin's disease: association with inflammatory bowel disease and immunosuppression. (2000) (119)
Surgical Pathology of the Lymph Nodes and Related Organs (1985) (119)
T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome. (1991) (119)
Low-grade lymphomas. Expression of developmentally regulated B-cell antigens. (1984) (119)
Cutaneous Lymphomatoid Granulomatosis: Correlation of Clinical and Biologic Features (2001) (119)
Heterogeneity of immunologic markers and surface morphology in childhood lymphoblastic lymphoma. (1976) (119)
Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin’s lymphoma and primary mediastinal large B-cell lymphoma (2011) (118)
Terminal deoxynucleotidyl transferase activity in malignant lymphomas. (1977) (118)
Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. (2013) (117)
Reticulum cell neoplasms of lymph nodes: a clinicopathologic study of 11 cases with recognition of a new subtype derived from fibroblastic reticular cells. (1998) (116)
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy. (1995) (116)
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. (2001) (115)
Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. (2014) (114)
Follicular Lymphomas in Children and Young Adults: A Comparison of the Pediatric Variant With Usual Follicular Lymphoma (2013) (114)
A Multidisciplinary Approach to Non-Hodgkin's Lymphomas (1981) (114)
A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma. (2000) (114)
The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. (1994) (114)
Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations (2011) (113)
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study. (2018) (113)
MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response (2012) (112)
An investigation of the viral pathogenesis of Kikuchi-Fujimoto disease. Lack of evidence for Epstein-Barr virus or human herpesvirus type 6 as the causative agents. (1994) (112)
Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications (2007) (112)
Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification. (2011) (112)
Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma (2018) (111)
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy (2011) (111)
Classification of cytotoxic T-cell and natural killer cell lymphomas. (2003) (111)
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma. (2007) (110)
Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma. (2015) (110)
Phenotypic expression of B-lymphocytes. 1. Identification with monoclonal antibodies in normal lymphoid tissues. (1984) (109)
World Health Organization Classification of lymphomas: a work in progress. (1998) (109)
Clinical Features and Outcomes of Patients With Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-associated Inflammation: Prospective Characterization of KSHV Inflammatory Cytokine Syndrome (KICS). (2016) (109)
Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. (1996) (109)
T‐Cell Lymphoblastic Lymphoma With Eosinophilia Associated With Subsequent Myeloid Malignancy (1992) (109)
Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic γδ T cell lymphoma (1997) (108)
Non-Hodgkin lymphoma in Jamaica and its relation to adult T-cell leukemia-lymphoma. (1987) (108)
CNS involvement in primary mediastinal large B-cell lymphoma. (1999) (108)
The human T-cell leukemia/lymphoma virus associated with American adult T-cell leukemia/lymphoma. (1983) (108)
Extramedullary myeloid cell tumors. An immunohistochemical study of 29 cases using routinely fixed and processed paraffin-embedded tissue sections. (1995) (107)
Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. (1993) (107)
Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma (2005) (107)
Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. (1995) (107)
A Druggable TCF4- and BRD4-Dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm. (2016) (107)
Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. (2005) (106)
Structural and functional properties of the „hairy”︁ cells of leukemic reticuloendotheliosis (1978) (106)
Nonhepatosplenic &ggr;&dgr; T-cell Lymphomas Represent a Spectrum of Aggressive Cytotoxic T-cell Lymphomas With a Mainly Extranodal Presentation (2011) (106)
Increased expression of the PRAD‐1/CCND1 gene in hairy cell leukaemia (1995) (105)
Lymphomatoid granulomatosis: pathogenesis, pathology and clinical implications. (1997) (105)
Peripheral T-Cell Lymphomas Expressing CD30 and CD15 (2003) (104)
Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma. (1991) (104)
Malignant lymphomas: pathology of hepatic involvement. (1987) (104)
Prolonged initial remission in patients with nodular mixed lymphoma. (1984) (103)
Vaccine-induced tumor-specific immunity despite severe B-cell depletion in mantle cell lymphoma (2005) (102)
Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas. (1995) (102)
Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. (2012) (101)
Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene. (2016) (100)
Primary follicular lymphoma of the testis in childhood (1999) (100)
The Histological and Biological Spectrum of Diffuse Large B-Cell Lymphoma in the World Health Organization Classification (2012) (99)
Lymphoblastic lymphoma presenting in cutaneous sites. A clinicopathologic analysis of six cases. (1991) (99)
Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas (2014) (98)
Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. (2002) (98)
Non-Hodgkin's Lymphoma in Job's Syndrome: A Case Report and Literature Review (2004) (97)
Lymphomatoid Granulomatosis—A Single Institute Experience: Pathologic Findings and Clinical Correlations (2015) (97)
Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers. (1980) (97)
Expression of human herpesvirus-8 oncogene and cytokine homologues in an HIV-seronegative patient with multicentric Castleman's disease and primary effusion lymphoma. (1998) (96)
Histogenetic correlations between subcategories of small noncleaved cell lymphomas. (1992) (95)
Recommended methods for cytological procedures in haematology. International Committee for Standardization in Haematology (ICSH). (1985) (95)
Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions. (1975) (95)
The Pathology of NK-Cell Lymphomas and Leukemias (2005) (95)
Peripheral T-cell Lymphomas of Follicular T-Helper Cell Derivation With Hodgkin/Reed-Sternberg Cells of B-cell Lineage: Both EBV-positive and EBV-negative Variants Exist (2013) (94)
Immunoblastic lymphadenopathy. Evolution into a malignant lymphoma with plasmacytoid features. (1976) (94)
B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. (1993) (94)
Peripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfalls (2013) (94)
Early lesions of follicular lymphoma: a genetic perspective (2014) (94)
Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray (2004) (93)
A prospective study of mediastinal gray-zone lymphoma. (2014) (93)
Cell volumes and dna distributions of normal and neoplastic human lymphoid cells (1978) (93)
Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis. (2003) (93)
Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. (1995) (92)
Precursor B-Lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature. (1998) (91)
Malignant lymphoma obscured by concomitant extensive epithelioid granulomas. Report of three cases with similar clinicopathologic features (1977) (91)
Pulmonary malignant lymphoma of mucosa-associated lymphoid tissue (MALT) arising in a pediatric HIV-positive patient. (1995) (91)
Lymphoproliferative disorders associated with congenital immunodeficiencies. (1997) (91)
Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression. (2014) (91)
Immunologic phenotypes of diffuse, aggressive, non‐Hodgkin's lymphomas. Correlation with clinical features (1984) (90)
Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. (1985) (90)
Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. (2007) (90)
Multicentric Castleman disease: Where are we now? (2016) (89)
Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL. (1985) (89)
Immunologic methods in cytology: definitive diagnosis of non-Hodgkin's lymphomas using immunologic markers for T- and B-cells. (1984) (88)
A proposal for classification of lymphoid neoplasms (by the International Lymphoma Study Group) (1994) (88)
Nasal and nasal‐type T/NK cell lymphoma: a unique form of lymphoma associated with the Epstein‐Barr virus (1995) (87)
A subset of Rosai–Dorfman disease cases show increased IgG4‐positive plasma cells: another red herring or a true association with IgG4‐related disease? (2014) (87)
The Role of Chemokines in Hodgkin's Disease (2000) (87)
The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease. (1986) (87)
Leukaemic phase of mantle zone (intermediate) lymphoma: its characterisation in 11 cases. (1989) (87)
Histiocytic sarcoma after acute lymphoblastic leukaemia: a common clonal origin. (2004) (86)
The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies. (1992) (86)
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment. (1991) (86)
Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas. (1982) (85)
Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the kidney. (1993) (84)
New Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraffin-Embedded Biopsies. (2017) (84)
T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Heterogeneous Entity With Derivation From Germinal Center B Cells (2002) (83)
Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas. (1996) (83)
Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation. (1999) (83)
Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. (1998) (83)
Gene rearrangements in the diagnosis of lymphoma/leukemia. Guidelines for use based on a multiinstitutional study. (1991) (83)
Cells of the marginal zone--origins, function and neoplasia. (2001) (82)
Diagnosis of Hodgkin lymphoma in the modern era (2018) (82)
The serine protease granzyme M is preferentially expressed in NK-cell, gamma delta T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity. (2003) (82)
Pathobiology of peripheral T-cell lymphomas. (2006) (82)
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma. (2016) (82)
Peripheral T/NK‐cell lymphoma: a report of the IXth Workshop of the European Assocation for Haematopathology (2001) (81)
Epstein‐Barr Virus Is Infrequently Identified in Non‐Hodgkin's Lymphomas Associated with Hodgkin's Disease (1994) (81)
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements (2016) (81)
Lymphoid Lesions of the Head and Neck: A Model of Lymphocyte Homing and Lymphomagenesis (2002) (81)
Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. (1997) (80)
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children (2011) (79)
Similarities of surface characteristics of neoplastic well-differentiated lymphocytes from solid tissues and from peripheral blood. (1976) (79)
Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas (1996) (79)
Inflammatory pseudotumor of the spleen. A clinicopathologic and immunophenotypic study of eight cases. (1993) (78)
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma (2016) (77)
c-myc protein in normal tissue. Effects of fixation on its apparent subcellular distribution. (1988) (77)
The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. (1996) (77)
Chronic Lymphocytic Leukemia with Coexistent Hodgkin's Disease: Implications for the Origin of the Reed‐Sternberg Cell (1991) (77)
Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt’s lymphoma (2008) (76)
Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions. (2005) (75)
Primary body cavity-based AIDS-related lymphomas. Evolution of a new disease entity. (1996) (75)
HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis. (2001) (75)
Chimeric fusion protein toxin DAB486IL-2 in advanced mycosis fungoides and the Sezary syndrome: correlation of activity and interleukin-2 receptor expression in a phase II study. (1994) (75)
Mutations in the coding region of c-MYC in AIDS-associated and other aggressive lymphomas. (1994) (75)
Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging. (2005) (75)
Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry. (2019) (74)
Thymoma: lymphoid and epithelial components mirror the phenotype of normal thymus. (1984) (73)
Accurate Classification of Diffuse Large B-Cell Lymphoma into Germinal Center and Activated B-Cell Subtypes Using a Nuclease Protection Assay on Formalin-Fixed, Paraffin-Embedded Tissues (2011) (73)
Cytotoxic T-cell and NK-cell Lymphomas: Current Questions and Controversies (2014) (73)
Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease. (1999) (73)
Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations. (1990) (73)
The Revised European‐American Classification of Lymphoid Neoplasms (REAL): a new perspective for the classification of cutaneous lymphomas (1997) (71)
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype. (2011) (71)
gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study. (2000) (71)
Human Autologous Tumor-Specific T-Cell Responses Induced by Liposomal Delivery of a Lymphoma Antigen (2004) (71)
Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases (2011) (70)
Automatic Classification of Lymphoma Images With Transform-Based Global Features (2010) (70)
Viral, immunologic, and clinical features of primary effusion lymphoma. (2019) (70)
Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival. (2012) (70)
Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago (1993) (70)
Histopathology of Hodgkin’s Lymphoma (2009) (70)
Genomic profiling of plasmablastic lymphoma using array comparative genomic hybridization (aCGH): revealing significant overlapping genomic lesions with diffuse large B-cell lymphoma (2009) (70)
Pathology of Castleman Disease. (2018) (70)
Clonal T-cell Populations and Increased Risk for Cytotoxic T-cell Lymphomas in B-CLL Patients: Clinicopathologic Observations and Molecular Analysis (2004) (70)
Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations. (1980) (69)
Quality control in immunohistochemistry. Report of a workshop sponsored by the Biological Stain Commission. (1989) (69)
The role of rituximab and chemotherapy in aggressive B-cell lymphoma: A preliminary report of dose-adjusted EPOCH-R. (2002) (68)
Molecular Profiling Provides Evidence of Primary Mediastinal Large B-Cell Lymphoma as a Distinct Entity Related to Classic Hodgkin Lymphoma: Implications for Mediastinal Gray Zone Lymphomas as an Intermediate Form of B-Cell Lymphoma (2004) (67)
Cyclin D 1 – negative mantle cell lymphoma : a clinicopathologic study based on gene expression profiling (2005) (67)
Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations. (2012) (67)
Immunologic and morphologic studies of T cell lymphoma. (1975) (67)
Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction. (1996) (67)
Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis. Clinical, pathologic, and immunologic features. (1987) (67)
Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases (2010) (66)
Molecular Diagnostics (2023) (65)
Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. (2016) (65)
Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Case report. (1996) (65)
Immunoblastic Lymphoma in Persons with AIDS-Associated Kaposi's Sarcoma: a Role for Kaposi's Sarcoma–Associated Herpesvirus (2003) (65)
Lymphocytic lymphoma of intermediate differentiation: morphologic, immunophenotypic, and prognostic factors. (1990) (65)
T-cell/histiocyte-rich large B-cell lymphoma (2010) (64)
Lymphoblastic lymphoma, a term rekindled with new precision. (1978) (63)
Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report (2009) (63)
IgD Positive L&H Cells Identify a Unique Subset of Nodular Lymphocyte Predominant Hodgkin Lymphoma (2006) (63)
IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. (2008) (63)
Mutations in the JAK/STAT and RAS signaling pathways are common in Intestinal T-cell Lymphomas (2016) (63)
Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR (2010) (63)
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma. (2012) (62)
EBV May Be Expressed in the LP Cells of Nodular Lymphocyte–predominant Hodgkin Lymphoma (NLPHL) in Both Children and Adults (2014) (62)
EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report—Part 1 (2017) (62)
Terminal deoxynucleotidyl transferase in non-Hodgkin's lymphoma. (1983) (61)
The investigation of epstein–barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt. Epidemiologic correlations (1995) (61)
A biophenotypic human herpesvirus 8--associated primary bowel lymphoma. (1999) (61)
PTEN Gene Alterations in Lymphoid Neoplasms (1998) (61)
Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? (2018) (61)
Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients (2016) (61)
Classification of T-cell and NK-cell neoplasms based on the REAL classification. (1997) (61)
The histological classification of diffuse large B-cell lymphomas. (2015) (60)
Hairy cell leukemia: a B cell neoplasm with a unique antigenic phenotype. (1983) (60)
Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12 (2000) (60)
Gall Bladder and Extrahepatic Bile Duct Lymphomas: Clinicopathological Observations and Biological Implications (2010) (60)
HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report—Part 3 (2017) (59)
Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival. (2013) (59)
Immunodeficiency‐Associated Malignant Lymphoma: Three Cases Showing Genotypic Evidence of Both T‐ and B‐Cell Lineages (1994) (59)
Hodgkin's disease in Mexico. Prevalence of Epstein‐Barr virus sequences and correlations with histologic subtype (1995) (59)
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphoma (2005) (58)
Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas. (1990) (58)
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL. (2017) (58)
Cutaneous lymphomas: a proposal for a unified approach to classification using the R.E.A.L./WHO Classification. (2000) (58)
Nasal Lymphomas in Peru (1993) (58)
Non-Hodgkin's Lymphomas Arising in Patients Successfully Treated for Hodgkin's Disease: A Clinical, Histologic, and Immunophenotypic Study of 14 Cases (1992) (58)
Nodal Involvement by Cutaneous CD30-positive T-cell Lymphoma Mimicking Classical Hodgkin Lymphoma (2012) (58)
Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling. (2012) (58)
bc1-1 rearrangement and cyclin D1 protein expression in multiple lymphomatous polyposis. (1996) (58)
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma (2013) (57)
Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation. (2017) (57)
CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma. (2019) (57)
The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases. (1984) (57)
Hairy cell leukemia: Enzyme histochemical characterization, with special reference to splenic stromal changes (1977) (57)
Lymphoma classification proposal: clarification. (1995) (57)
Cutaneous manifestations of lymphoma: a clinical guide based on the WHO classification. World Health Organization. (2001) (57)
Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma. (2020) (56)
Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus. (1998) (56)
HLA-DR, HLA-DQ, and TAP genes in familial Hodgkin disease. (2002) (56)
T‐cell‐rich B‐cell lymphoma presenting in skin (1996) (55)
In vivo administration of purified Jurkat-derived interleukin 2 in mice. (1984) (55)
The surgical pathology of gastrointestinal Hodgkin's disease. (1991) (55)
Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome. (2009) (55)
The role of immunophenotypic markers in the classification of non-Hodgkin's lymphomas. (1990) (55)
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma. (2014) (55)
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. (2006) (54)
Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas. (1995) (54)
WHO ) classification of lymphoid neoplasms (2016) (54)
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP. (1991) (54)
Evolution of a lymphoma with helper T cell characteristics in Sézary syndrome. (1978) (54)
NIH conference. Angioimmunoblastic lymphadenopathy with dysproteinemia. (1988) (54)
End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making (2018) (54)
Non‐Hodgkin's lymphomas. Application of the international classification of diseases for oncology (ICD‐O) to the working formulation (1984) (53)
Complete Sustained Response of a Refractory, Post-Transplantation, Large B-Cell Lymphoma to an Anti-CD22 Immunotoxin (1997) (53)
Primary Cutaneous Peripheral T-Cell Lymphoma, Rare Subtype (2008) (53)
Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets. (2017) (53)
Subcutaneous panniculitis‐like T‐cell lymphoma in the pediatric age group: A lymphoma of low malignant potential (2013) (52)
Romidepsin in peripheral and cutaneous T‐cell lymphoma: mechanistic implications from clinical and correlative data (2015) (52)
Introduction to the WHO Classification (1997) (52)
Cytokine receptor signaling is required for the survival of ALK− anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations (2017) (52)
Small Noncleaved Cell Lymphoma Associated with Florid Epithelioid Granulomatous Response: A Clinicopathologic Study of Seven Patients (1993) (51)
Hepatosplenic gamma delta T cell lymphoma (1999) (51)
Aggressive Langerhans cell histiocytosis following T‐ALL: Clonally related neoplasms with persistent expression of constitutively active NOTCH1 (2008) (51)
Nature and importance of follicular lymphoma precursors (2014) (51)
Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States. (1985) (51)
Hodgkin's disease of Waldeyer's ring. Clinical and histoimmunophenotypic findings and association with Epstein-Barr virus in 16 cases. (1995) (51)
Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells (1987) (50)
Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens. (2018) (50)
Elevated serum-soluble interleukin-2 receptor levels in patients with anaplastic large cell lymphoma. (2004) (50)
Pathobiology and Treatment of Lymphomatoid Granulomatosis; A Rare EBV-Driven Disorder. (2020) (50)
Primary Cutaneous CD30-Positive Anaplastic Large Cell Lymphoma in Childhood: Report of 4 Cases and Review of the Literature (2005) (50)
Acute megakaryoblastic leukemia in childhood (1984) (50)
MIP-1alpha expression in tissues from patients with hemophagocytic syndrome. (1999) (49)
evolving concepts and practical applications The 2008 WHO classification of lymphoid neoplasms and beyond (2011) (49)
EBV-negative Aggressive NK-cell Leukemia/Lymphoma: Clinical, Pathologic, and Genetic Features (2017) (49)
The elusive Reed-Sternberg cell. (1989) (49)
Epstein-Barr virus-associated T-cell lymphoma in a renal transplant patient. (1993) (49)
Follicular lymphomas with plasmacytic differentiation include two subtypes (2010) (49)
Expression of potentially oncogenic HHV‐8 genes in an EBV‐negative primary effusion lymphoma occurring in an HIV‐seronegative patient (1999) (48)
Use of CD23 (BU38) on paraffin sections in the diagnosis of small lymphocytic lymphoma and mantle cell lymphoma. (1996) (48)
Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma (2019) (48)
CD5 Expression in B‐Cell Small Lymphocytic Malignancies: Correlations with Clinical Presentation and Sites of Disease (1992) (48)
Macrophage-Derived Chemokine Expression in Classical Hodgkin's Lymphoma: Application of Tissue Microarrays (2001) (48)
Histologically discordant lymphomas with B-cell and T-cell components. (1997) (48)
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling (2015) (48)
ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements (2013) (48)
Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis (2015) (47)
Early lymphoid lesions: conceptual, diagnostic and clinical challenges (2014) (47)
Primary Mediastinal Large B-Cell Lymphoma, Classic Hodgkin Lymphoma Presenting in the Mediastinum, and Mediastinal Gray Zone Lymphoma: What is the Oncologist To Do? (2011) (47)
Hematopathology: integration of morphologic features and biologic markers for diagnosis. (1999) (46)
Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity (2015) (46)
Flow cytometric immunophenotypic profiles of mature gamma delta T‐cell malignancies involving peripheral blood and bone marrow (2005) (46)
90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin’s lymphoma (2015) (46)
Anti-tumor activities of the angiogenesis inhibitors interferon-inducible protein-10 and the calreticulin fragment vasostatin (2002) (46)
The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma. (2019) (45)
Molecular genetics of gastrointestinal non-Hodgkin‧s lymphomas: unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas (1990) (45)
Gray Zone Lymphoma: Better Treated Like Hodgkin Lymphoma or Mediastinal Large B-Cell Lymphoma? (2012) (45)
Lymphoid Proliferations of Indeterminate Malignant Potential arising in Adults with Common Variable Immunodeficiency Disorders: Unusual Case Studies and Immunohistological Review in the Light of Possible Causative Events (2011) (45)
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease. (1997) (45)
Diffuse large cell lymphomas (reticulum cell sarcomas, histiocytic lymphomas). Correlation of morphologic features with functional markers (1980) (44)
Multilocular thymic cysts: imaging features in children with human immunodeficiency virus infection. (1996) (43)
An overview of the classification of non-Hodgkin's lymphomas: an integration of morphological and phenotypical concepts. (1992) (43)
Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomas. (1998) (43)
Presence of intracytoplasmic IgG in the lymphocytic infiltrates of the minor salivary glands of patients with primary Sjögren's syndrome. (1983) (43)
Current concepts of leukemia and lymphoma: etiology, pathogenesis, and therapy. (1976) (43)
Epstein-Barr virus in nasal lymphomas contains multiple ongoing mutations in the EBNA-1 gene. (1998) (43)
Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation. (2004) (43)
IgG4‐related disease presenting as recurrent mastoiditis (2012) (43)
Best Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma. (2020) (42)
Adult T‐Cell leukemia/lymphoma: A working point‐score classification for epidemiological studies (1994) (42)
Low‐Grade Follicular Lymphoma of the Small Intestine (2002) (42)
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy. (1994) (41)
Phenotypic expression of T lymphocytes in thymus and peripheral lymphoid tissues. (1985) (41)
CD5+ follicular lymphoma: a clinicopathologic study of three cases. (2002) (41)
Expression of the Interferon Regulatory Factor 8/ICSBP-1 in Human Reactive Lymphoid Tissues and B-cell Lymphomas: A Novel Germinal Center Marker (2008) (41)
Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups (2019) (41)
The prognostic significance of lymphopenia in peripheral T‐cell and natural killer/T‐cell lymphomas: A study of 826 cases from the International Peripheral T‐cell Lymphoma Project (2012) (41)
The revised European-American Classification of Lymphoid Neoplasms (REAL): a preferred approach for the classification of cutaneous lymphomas. (1999) (41)
Polyarteritis nodosa, hairy cell leukemia and splenosis. (1981) (41)
Final Results of a Phase 2 NCI Multicenter Study of Romidepsin in Patients with Relapsed Peripheral T-Cell Lymphoma (PTCL). (2008) (41)
SURFACE CHARACTERISTICS OF HODGKIN'S LYMPHOMA CELLS (1974) (40)
Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locus (2011) (40)
Development of disseminated histiocytic sarcoma in a patient with autoimmune lymphoproliferative syndrome and associated Rosai-Dorfman disease. (2010) (40)
Flow cytometric detection of neoplastic T cells in patients with mycosis fungoides based on levels of T-cell receptor expression. (1994) (40)
Utility of monoclonal antibodies directed against B and T lymphocytes and monocytes in paraffin-embedded sections. (1983) (39)
Cutaneous EBV-related lymphoproliferative disorders. (2017) (39)
A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome. (2018) (39)
Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphoma. (1997) (39)
Frequent occurrence of deletions in primary mediastinal B‐cell lymphoma (2007) (39)
Human herpesvirus-6-associated acute lymphadenitis in immunocompetent adults (2004) (38)
A new molecular assay and genomic complexity predict outcome in conventional and leukemic non-nodal mantle cell lymphoma (2018) (38)
Atypical NK-cell Proliferation of the Gastrointestinal Tract in a Patient With Antigliadin Antibodies but not Celiac Disease (2006) (38)
PD-1 Blockade in Mediastinal Gray-Zone Lymphoma. (2017) (38)
Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease. (2020) (38)
Multilocular thymic cysts in children with human immunodeficiency virus infection: clinical and pathologic aspects. (1997) (38)
Light‐chain‐restricted germinal centres in reactive lymphadenitis: report of eight cases (2008) (38)
Effective targeting of tumor vasculature by the angiogenesis inhibitors vasostatin and interleukin-12. (2000) (37)
Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. (2010) (37)
B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report—Part 2 (2017) (37)
Phenotypic expression of B-lymphocytes. 2. Immunoglobulin expression of germinal center cells. (1984) (36)
Tumors of the Lymph Nodes and Spleen. Atlas of Tumor Pathology (1996) (35)
The histiocytoses: clinical presentation and differential diagnosis. (1990) (35)
Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease. (2004) (35)
Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study. (2000) (35)
Multiple recurrences of acute tumor lysis syndrome in an indolent non‐hodgkin's lymphoma (1985) (35)
Microcystic adnexal carcinoma associated with primary immunodeficiency, recurrent diffuse herpes simplex virus infection, and cutaneous T-cell lymphoma. (2000) (35)
Mediastinal lymphoblastic lymphoma with an immature B-cell immunophenotype. (1992) (34)
Bone Involvement in Young Patients With Non-Hodgkin's Lymphoma: Efficacy of Chemotherapy Without Local Radiotherapy (1988) (34)
A comparison of ABC, unlabeled antibody and conjugated immunohistochemical methods with monoclonal and polyclonal antibodies--an examination of germinal center of tonsils. (1983) (34)
Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation. (2013) (34)
Human T-cell lymphotropic virus type I and adult T-cell leukemia/lymphoma outside Japan and the Caribbean Basin. (1988) (34)
Hodgkin's Disease Following Non-Hodgkin's Lymphoma: A Clinicopathologic and Immunophenotypic Study of Nine Cases (1993) (34)
Nodular Lymphocyte-Predominant Hodgkin Lymphoma With Atypical T Cells: A Morphologic Variant Mimicking Peripheral T-Cell Lymphoma (2011) (34)
Aggressive NK cell lymphomas: insights into the spectrum of NK cell derived malignancies (2000) (34)
Malignant Lymphomas of B‐Cell Lineage with Marked Tissue Eosinophilia: A Report of Five Cases (1994) (34)
Mantle cell lymphoma: an update. (1992) (33)
Molecular analysis of light-chain switch and acute lymphoblastic leukemia transformation in two follicular lymphomas: Implications for lymphomagenesis (2006) (33)
Malignant lymphoma involving a Warthin's tumor: a case with immunophenotypic and gene rearrangement analysis. (1990) (32)
Cytogenetic study of two cases with lymphoma of mucosa-associated lymphoid tissue. (1994) (32)
Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3−/dimCD4+ population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic (2016) (32)
The effect of ethnic differences on the pattern of HTLV‐I‐associated T‐cell leukemia/lymphoma (HATL) in the United States (1994) (32)
IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas. (2018) (32)
BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma. (2014) (32)
Lymphoma in acquired generalized lipodystrophy (2016) (32)
Breast implant‐associated anaplastic large cell lymphoma in a patient with Li–Fraumeni syndrome (2015) (32)
The Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 Modulates Chronic Active BCR Signaling and Induces Tumor Regression in Relapsed/Refractory ABC DLBCL (2011) (32)
Adult T-Cell Leukemia/Lymphoma (2011) (32)
Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1–Associated Adult T-cell Leukemia/lymphoma (2016) (31)
Histopathologic subtypes of indolent lymphomas: caricatures of the mature B-cell system. (1993) (31)
Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in Caucasians. (2019) (31)
Lymphomatoid papulosis associated with Ki‐1‐positive anaplastic large cell lymphoma. A report of two cases and a review of the literature (1994) (31)
Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas. (1998) (31)
Hodgkin's disease following non‐Hodgkin's lymphoma (1992) (30)
c-myc mRNA expression in minor salivary glands of patients with Sjögren's syndrome. (1992) (30)
Nodal Marginal Zone Lymphoma (2000) (30)
Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features. (1999) (30)
A comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non‐Hodgkin's lymphoma (1979) (30)
Early lesions in lymphoid neoplasia (2012) (30)
Development of a second clonally discrete Burkitt's lymphoma in a human immunodeficiency virus-positive homosexual patient. (1988) (29)
CREBBP gene mutations are frequently detected in in situ follicular neoplasia. (2018) (29)
Phase I Study of Dose-Adjusted-Teddi-R with Ibrutinib in Untreated and Relapsed/Refractory Primary CNS Lymphoma (2015) (29)
Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma (1981) (29)
Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting (2019) (29)
Marginal zone B-cell lymphoma with monocytoid B-cell lymphocytes in pediatric patients without immunodeficiency. A report of two cases. (1997) (29)
Metachronous EBV-associated B-cell and T-cell Posttransplant Lymphoproliferative Disorders in a Heart Transplant Recipient (2009) (29)
Prevalence of Epstein-Barr viral sequences and EBV LMP1 oncogene deletions in Burkitt's lymphoma from Pakistan: epidemiological correlations. (1997) (28)
Acute lymphoblastic leukemia–hand mirror cell variant: A detailed cytological and ultrastructural study with an analysis of the immunologic surface markers (1978) (28)
Rearrangement of both immunoglobulin and T-cell receptor genes in a prolymphocytic variant of hairy cell leukemia patient resistant to interferon-alpha. (1988) (28)
Cytomegalovirus-infected cells express Leu-M1 antigen. A potential source of diagnostic error. (1990) (28)
Periodic illness associated with Epstein-Barr virus infection. (1996) (28)
Lymphomatoid Granulomatosis and Angiocentric Lymphoma: A Spectrum of Post-Thymic T-Cell Proliferations (1989) (27)
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma (2021) (27)
Recurrent somatic JAK3 mutations in NK-cell enteropathy. (2019) (27)
Immunological phenotypic pattern of acute lymphoblastic leukaemia in Egypt. (1989) (27)
Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large B-cell lymphoma. (2013) (26)
Coexisting Hodgkin's disease and mycosis fungoides. Immunohistochemical proof of its existence. (1986) (26)
Primary cutaneous Hodgkin's disease with evolution to systemic disease. Association with the Epstein-Barr virus. (1996) (26)
Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome May Be Significantly Improved by the Addition of Rituximab to Dose-Adjusted (DA)-EPOCH and Obviates the Need for Radiation: Results from a Prospective Study of 44 Patients. (2006) (26)
Hairy cell leukemia diagnostic criteria and differential diagnosis (2011) (26)
Fluorodeoxyglucose positron emission tomography (FDG‐PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS) (2006) (26)
Late-Onset Severe Chronic Active EBV in a Patient for Five Years with Mutations in STXBP2 (MUNC18-2) and PRF1 (Perforin 1) (2015) (26)
Aberrations of MYC are a common event in B-cell prolymphocytic leukemia. (2014) (26)
KSHV-associated and EBV-associated Germinotropic Lymphoproliferative Disorder: New Findings and Review of the Literature. (2017) (26)
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma (2020) (26)
Structural profiles of TP 53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma : an international collaborative study (2008) (25)
ATYPICAL LYMPHOPROLIFERATIVE DISORDERS (2010) (25)
Rearrangement of the T-cell receptor delta chain gene in T-cell lymphomas with a mature phenotype. (1991) (25)
Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract (2018) (25)
Diagnosis and classification of lymphoma: Impact of technical advances. (2019) (25)
Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report. (2005) (25)
Phase I trial of 7-hydroxystaurosporine and fludararbine phosphate: in vivo evidence of 7-hydroxystaurosporine induced apoptosis in chronic lymphocytic leukemia (2011) (25)
Epstein-Barr virus-associated inflammatory pseudotumor presenting as a colonic mass. (2015) (24)
Phase I/II study of Bortezomib Alone and Bortezomib with Dose-Adjusted EPOCH Chemotherapy in Relapsed or Refractory Aggressive B-Cell Lymphoma. (2004) (24)
Expanding the Spectrum of EBV-positive Marginal Zone Lymphomas: A Lesion Associated With Diverse Immunodeficiency Settings (2018) (24)
IL-21-driven neoplasms in SJL mice mimic some key features of human angioimmunoblastic T-cell lymphoma. (2015) (24)
IRF4-rearranged Large B-cell lymphoma (LBCL) has a genomic profile distinct to other LBCL in children and young adults. (2019) (24)
Malignant thymoma associated with T-cell lymphocytosis. A case report with immunophenotypic and gene rearrangement analysis. (1993) (24)
Nodal and Extranodal Plasmacytomas Expressing Immunoglobulin A: An Indolent Lymphoproliferative Disorder With a Low Risk of Clinical Progression (2010) (23)
Monoclonal antibodies directed against human lymphoid, monocytic, and granulocytic cells: reactivities with other tissues. (1983) (23)
In situ hybridization detection of human herpesvirus 6 in biopsy specimens from Chinese patients with non-Hodgkin's lymphoma. (1993) (23)
My4 antibody staining of non-Hodgkin's lymphomas. (1991) (23)
Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice. (2017) (23)
CD15‐expressing nodular lymphocyte‐predominant Hodgkin lymphoma (2011) (22)
Florid CD4+, CD56+ T-Cell Infiltrate Associated with Herpes Simplex Infection Simulating Nasal NK-/T-Cell Lymphoma (2003) (22)
Phase II trial of dose-adjusted EPOCH in untreated systemic anaplastic large cell lymphoma (2016) (22)
T-cell-rich B-cell lymphomas [1] (1991) (22)
The incidence of hepatosplenic T‐cell lymphoma in a large managed care organization, with reference to anti‐tumor necrosis factor therapy, Northern California, 2000–2006 (2012) (22)
Mantle cell lymphoma: A cytopathological and immunocytochemical study (1996) (22)
Relationship of p 53 , bcl-2 , and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin ’ s Lymphomas (1997) (22)
CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression (2009) (21)
Gene Expression Signatures Predict Overall Survial in Diffuse Large B Cell Lymphoma Treated with Rituximab and Chop-Like Chemotherapy. (2007) (21)
Epstein-Barr virus and familial Hodgkin's disease. (1996) (21)
CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma (2020) (21)
An immunohistochemical study of the bone marrow lesions of systemic mastocytosis: expression of stem cell factor by lesional mast cells. (2002) (21)
Coexisting and Clonally Identical Classic Hodgkin Lymphoma and Nodular Lymphocyte Predominant Hodgkin Lymphoma (2011) (21)
Characteristics and outcomes of KSHV-associated multicentric Castleman disease with or without other KSHV diseases. (2021) (21)
Surface receptors of human neoplastic lymphoreticular cells. (1977) (21)
T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report—Part 4 (2017) (21)
Metastatic nasopharyngeal carcinoma initially presenting as cervical lymphadenopathy. A report of two cases that resembled Hodgkin's disease. (1992) (20)
Primary Mediastinal Large B-Cell Lymphoma (PMBL) Outcome Is Significantly Improved by the Addition of Rituximab to Dose Adjusted (DA)-EPOCH and Overcomes the Need for Radiation. (2005) (20)
A study of adult T‐cell leukemia/lymphoma incidence in central Brooklyn (1999) (20)
Recommendations for the reporting of lymphoid neoplasms: A report from the Association of Directors of Anatomic and Surgical Pathology (2004) (20)
The genetic landscape of dural marginal zone lymphomas (2016) (20)
Unusual immunophenotype of CD8+ T cells in familial hemophagocytic lymphohistiocytosis. (2004) (20)
Mature T-cell and NK-cell lymphomas in the pediatric age group. (2004) (20)
Distribution of complement receptor subtypes in non-Hodgkin's lymphomas of B-cell origin (1981) (20)
Aggressive Epstein-Barr Virus-Associated, CD8+, CD30+, CD56+, Surface CD3−, Natural Killer (NK)-Like Cytotoxic T-Cell Lymphoma (2002) (19)
Granulomatous reaction in Burkitt lymphoma: correlation with EBV positivity and clinical outcome. (2005) (19)
Absence of p18 mutations or deletions in lymphoid malignancies. (1996) (19)
Clonal Epstein–Barr virus-positive mucocutaneous ulcer mimicking a mature B-cell lymphoma in a patient with mycophenolate-induced immune suppression (2015) (19)
How I Diagnose Angioimmunoblastic T-Cell Lymphoma. (2021) (19)
Phase 1 study of combination rituximab with apolizumab in relapsed/refractory B-cell lymphoma and chronic lymphocytic leukemia (2005) (19)
Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T‐cell lymphomas: a clinicopathologic study of three cases (2014) (19)
Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains. (1995) (19)
B Lymphoblastic Leukemia/Lymphoma With Burkitt-like Morphology and IGH/MYC Rearrangement: Report of 3 Cases in Adult Patients (2018) (19)
HHV-8-positive but EBV-negative primary effusion lymphoma. (2013) (18)
Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD (2004) (18)
Epstein-Barr Virus–Positive Primary Gastrointestinal Hodgkin's Disease (2000) (18)
Burkitt’s Lymphoma: A Single Disease With Multiple Variants (1999) (18)
Lymph node aspiration in the management of Hodgkin's disease. (1986) (18)
Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation (2017) (18)
Genotypic analysis of diffuse, mixed cell lymphomas. Comparison with morphologic and immunophenotypic findings. (1991) (18)
Horizontal Transmission of Malignancy: In-Vivo Fusion of Human Lymphomas with Hamster Stroma Produces Tumors Retaining Human Genes and Lymphoid Pathology (2013) (18)
Immune Characteristics Associated with Lymphomatoid Granulomatosis and Outcome Following Treatment with Interferon-Alpha (2010) (17)
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy (2020) (17)
Mucocutaneous ulcer: a mimic of EBV + diffuse large B cell lymphoma in the immunodeficiency setting (2016) (17)
ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female (2019) (17)
S-100-positive T-cell lymphoproliferative disorder. A case report and review of the literature. (1994) (17)
Pathobiology of T-cell and NK-cell lymphomas. (2013) (17)
Synovitis in angioimmunoblastic lymphadenopathy with dysproteinemia simulating rheumatoid arthritis. (1990) (17)
Lymphoma Classification. (2020) (17)
Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms. (2022) (17)
Malignant lymphomas as tumours of the immune system. (1980) (17)
Novel Treatment of Burkitt Lymphoma with Dose-Adjusted EPOCH-Rituximab: Preliminary Results Showing Excellent Outcome. (2006) (17)
Concurrent Expression Of MYC/BCL2 Protein In Newly Diagnosed DLBCL Is Not Associated With An Inferior Survival Following EPOCH-R Therapy (2013) (17)
Genome‐wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features (2013) (17)
Lymphomatoid granulomatosis with involvement of the hard palate: a case report. (2008) (16)
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder (2020) (16)
Solitary extramedullary plasmacytoma of the vocal cord in an adolescent. (2009) (16)
Terminal transferase activity and lymphoblastic neoplasms. (1984) (16)
Induction of immunoglobulin secretion in follicular non-Hodgkin's lymphomas: role of immunoregulatory T cells (1985) (16)
Circulating Tumor DNA Dynamics during Therapy Predict Outcomes in Mantle Cell Lymphoma (2018) (16)
Lymph node pathology of HTLV and HTLV-associated neoplasms. (1985) (16)
Navigating the cutaneous B-cell lymphomas: avoiding the rocky shoals (2019) (15)
A Pilot Trial of Campath-1H and Dose-Adjusted EPOCH in CD52-Expressing Aggressive T-Cell Malignancies. (2005) (15)
Transformation of follicular lymphoma to Epstein-Barr virus-related Hodgkin-like lymphoma. (2013) (15)
A study of PD‐L1 expression in intravascular large B cell lymphoma: correlation with clinical and pathological features (2019) (15)
Association of EBV Strains, Defined by Multiple Loci Analyses, in Non-Hodgkin Lymphomas and Reactive Tissues from HIV Positive and HIV Negative Patients (2000) (15)
Objective regressions of T- and B-cell lymphomas in patients following treatment with anti-thymocyte globulin. (1982) (15)
Intravascular large cell lymphoma of NK/T-cell type, EBV positive. (2017) (15)
Histiocytoses of lymph nodes: biology and differential diagnosis. (1988) (15)
Low-grade monoclonal Epstein-Barr virus-associated lymphoproliferative disorder of the brain presenting as human immunodeficiency virus-associated encephalopathy in a child with acquired immunodeficiency syndrome. (1999) (15)
Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma. (2020) (15)
Novel markers in pediatric-type follicular lymphoma (2019) (15)
Burkitt's/Burkitt's-like lymphoma presenting as bacterial sinusitis in two HIV-infected children. (2001) (14)
Gene Expression Differences between Low and High Stage Diffuse Large B Cell Lymphoma (DLBCL). (2006) (14)
Diagnosing central nervous system lymphoma in the setting of AIDS: a step forward. (1998) (14)
NUT Rearrangement is Uncommon in Human Thymic Epithelial Tumors (2012) (14)
Aggressive Natural Killer Cell Leukemia/Lymphoma: Case Report, use of Telesynergy™ and Review of the Literature (2004) (14)
Treatment of HIV-associated Primary CNS Lymphoma with Antiretroviral Therapy, Rituximab, and High-Dose Methotrexate. (2020) (14)
Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms. (1993) (14)
Comparative Clinical and Biological Features of Primary Mediastinal B-Cell Lymphoma (PMBL) and Mediastinal Grey Zone Lymphoma (MGZL). (2009) (14)
Lack of identifiable vascular invasion in patients with extranodal dissemination of hodgkin's disease (1973) (14)
Kaposi's sarcoma in human T-cell leukemia virus type I-associated adult T-cell leukemia. (1990) (14)
Hepatosplenic T-cell Lymphoma of αβ Lineage (2001) (14)
Protocol for the examination of specimens from patients with non-Hodgkin lymphoma/lymphoid neoplasms. (2010) (14)
Induction of immunoglobulin secretion in follicular non-Hodgkin's lymphomas: role of immunoregulatory T cells. (1985) (13)
BCL 2 Translocation Defines a Unique Tumor Subset within the Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma (2016) (13)
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R (2018) (13)
Chemotherapy for lymphoma in a patient with common variable immunodeficiency: case report, literature review, and recommendations for chemotherapy in immunodeficient patients. (1982) (13)
IMMUNODIAGNOSIS OF LYMPHOID AND MONONUCLEAR PHAGOCYTIC NEOPLASMS (1985) (13)
Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status (2016) (13)
Efficacy and toxicity of dose-adjusted EPOCH-rituximab in adults with newly diagnosed Burkitt lymphoma (2007) (13)
Why is it crucial to reintegrate pathology into cancer research? (2011) (13)
Cardiac involvement with human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: The NIH experience (2008) (13)
Clinical and Histopathologic Features of Interstitial Lung Disease in Erdheim–Chester Disease (2018) (13)
Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma (2019) (12)
Cutaneous gamma/delta T‐cell lymphoma (2009) (12)
Regression and Clonally Distinct Recurrence of Human Immunodeficiency Virus Related Burkitt-Like Lymphoma During Antiretroviral Therapy (2001) (12)
Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes. (2017) (12)
Chromosomal Imbalances in Germinal Center B-Cell-Like and Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Influence Gene Expression Signatures and Improve Gene Expression-Based Survival Prediction(the First Two Authors Contributed Equally to This Work). (2004) (12)
A Prospective Trial of Radiation Alone vs Combination Chemotherapy Alone for Early-Stage Hodgkin’s Disease: Implications of 25-Year Follow-Up to Current Combined Modality Therapy. (2006) (12)
Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival (2008) (12)
Chapter 1 – Classification and Histopathology of the Lymphomas (2006) (12)
Phase 1b/2 Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis (2020) (12)
Primary/Congenital Immunodeficiency: 2015 SH/EAHP Workshop Report—Part 5 (2017) (11)
Bortezomib + DA-EPOCH-R Induction Therapy Followed by Maintenance Bortezomib Versus Observation in Newly Diagnosed Mantle Cell Lymphoma (2012) (11)
Mantle cell lymphoma. Accurate diagnosis yields new clinical insights. (1996) (11)
Report of the symposium on Cutaneous Lymphomas: Sixth International Conference on Malignant Lymphoma. (1997) (11)
Bone involvement in young patients with non-Hodgkin's lymphoma: efficacy of chemotherapy without local radiotherapy. (1988) (11)
Phase II trial of daclizumab in human T-cell lymphotropic virus type-1 (HTLV-1)-associated adult T-cell leukemia/lymphoma (ATL). (2010) (11)
Enteropathy-type T-cell lymphoma after intestinal diffuse large B-cell lymphoma. (2007) (11)
Epstein-Barr Virus in Nasal Lymphomas Contains Multiple Ongoing Mutations in the EBNA-1 Gene (1998) (11)
Abbreviated Treatment with Short-Course Dose-Adjusted EPOCH and Rituximab (DA-EPOCH-R) Is Highly Effective in AIDS-Related Lymphoma (ARL). (2004) (11)
STIMULATION OF PHAGOCYTOSIS BY A T CELL LYMPHOMA-DERIVED LYMPHOKINE (1982) (11)
The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-R. (2002) (11)
Allelic loss of 11q13 as detected by MEN1-FISH is not associated with mutation of the MEN1 gene in lymphoid neoplasms (1999) (11)
Lymphocyte analysis in a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency after development of echovirus dermatomyositis and meningoencephalitis. (1989) (11)
T‐cell lymphoma in Singapore: pathology, clinical findings and association with HTLV‐1 antibodies (1992) (11)
Chemokine Gene Expression and Clonal Analysis of B Cells in Tissues Involved by Lymphoid Interstitial Pneumonitis from HIV-Infected Pediatric Patients (2001) (11)
Follicular center cell lymphoma with the t(14;18) translocation in which the rearranged BCL-2 gene is silent. (1993) (11)
Case 48-1981:ultrasound in the diagnosis of uremic disease in adults. (1982) (10)
Retroviruses in human leukemia (2007) (10)
Monitoring of Circulating Tumor DNA As Minimal Residual Disease in Diffuse Large B-Cell Lymphoma (2014) (10)
Crystal-storing histiocytosis associated with thymic extranodal marginal zone lymphoma. (2017) (10)
Pulmonary lymphocytic angiitis: a nosologic quandary. (1988) (10)
Mutation of the ras genes is a rare genetic event in the histologic transformation of follicular lymphoma. (1996) (10)
Immunodeficiency and Dysregulation: Report of the 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology. (2017) (10)
Immunophenotypic analysis of acute lymphoblastic leukemia using routinely processed bone marrow specimens. (1991) (10)
Myeloproliferative syndromes: a unique presentation of chronic myelogenous leukemia (CML) as a primary tumor of bone. (1978) (10)
HTLV-associated diseases: human retroviral infection and cutaneous T-cell lymphomas. (1997) (10)
Recommendations for the reporting of lymphoid neoplasms: a report from the Association of Directors of Anatomic and Surgical Pathology. The Ad Hoc Committee on reporting of lymphoid neoplasms. (2002) (9)
Gammaherpesvirus infection and malignant disease in rhesus macaques experimentally infected with SIV or SHIV (2018) (9)
Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV (2009) (9)
Dose-Adjusted EPOCH-Rituximab Is Highly Effective in the GCB and ABC Subtypes of Untreated Diffuse Large B-Cell Lymphoma. (2004) (9)
Distribution of complement receptor subtypes in non-Hodgkin's lymphomas of B-cell origin. (1981) (9)
disease discovery Classification of lymphoid neoplasms: the microscope as a tool for (2008) (9)
Antineutrophil Cytoplasmic Autoantibody–Associated Systemic Vasculitis is Associated With Epstein-Barr Virus in the Setting of HIV Infection (2013) (9)
Gray Zone Lymphomas: Clinical and Histological Characteristics and Treatment with Dose-Adjusted-EPOCH-R (2008) (9)
Determination of lineage and clonality in diffuse lymphomas using the polymerase chain reaction technique. (1991) (9)
A multiprotein supercomplex controlling oncogenic signalling in lymphoma (2018) (9)
HIV-associated non-Hodgkin’s lymphoma (1997) (8)
DA-EPOCH Chemotherapy Is Highly Effective in ALK-Positive and ALK-Negative ALCL: Results of a Prospective Study of PTCL Subtypes in Adults (2011) (8)
Phenotypic analysis of T-cell acute lymphoblastic leukemia in Egypt. (1990) (8)
T-cell-rich B-cell lymphomas. (1991) (8)
Primary diffuse large B‐cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids (2007) (8)
Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20. (2011) (8)
The Microscope as a Tool for Disease Discovery-A Personal Voyage. (2017) (8)
Thymoma with abundant L26-positive 'asteroid' cells. A case report with an analysis of normal thymus and thymoma specimens. (1991) (8)
DA-EPOCH-R Is Highly Effective in Both BCL-6+ and BCL-6− Untreated De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Study Update and Analysis of Survival Outcomes for Multiple Biomarkers. (2006) (8)
Phase I/II study of a hybrid schedule of flavopiridol in relapsed/refractory mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL). (2016) (8)
Long-Term Outcome of AIDS-Related Lymphoma Treated with Abbreviated Cycles of EPOCH-RR: A Prospective Study of 40 Patients (2008) (7)
Phase II Study of Interferon-Alpha and DA-EPOCH+/-R in Lymphomatoid Granulomatosis (2018) (7)
The Morphologic Spectrum of T-Cell Lymphoma (1988) (7)
Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities (2019) (7)
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice (2022) (7)
Genetic diversity in melanoma metastases from a patient with xeroderma pigmentosum. (2010) (7)
Circulating tumor DNA to predict timing of relapse in mantle cell lymphoma. (2018) (7)
Increased CD5‐positive polyclonal B cells in Castleman disease: a diagnostic pitfall (2013) (7)
Multicentric Castleman disease and the evolution of the concept (2021) (7)
Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice. (2017) (7)
Dose-Adjusted Teddi-R Induces Durable Complete Remissions in Relapsed and Refractory Primary CNS Lymphoma (2018) (7)
An Enteropathy-like Indolent NK-Cell Proliferation Presenting in the Female Genital Tract. (2020) (7)
Nasal NK/T cell lymphoma mimicking a squamous cell carcinoma: a case report. (2005) (7)
Lymphoproliferative diseases associated with primary immune disorders (2017) (7)
PNMZL and PTFL: morphological variants with a common molecular profile - a unifying hypothesis. (2022) (7)
New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders (2022) (7)
Follicular lymphomas: possibility that they are benign tumors of the lymphoid system. (1983) (7)
Preliminary Results of a Response-Adapted Study of Ibrutinib and Isavuconazole with Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) for Secondary CNS Lymphoma (2020) (6)
Phase 1/2 study of alemtuzumab with dose-adjusted EPOCH in untreated aggressive T and NK cell lymphomas (2019) (6)
Integrative Genetic and Clinical Analysis through Whole Exome Sequencing in 1001 Diffuse Large B Cell Lymphoma (DLBCL) Patients Reveals Novel Disease Drivers and Risk Groups (2016) (6)
DA-EPOCH-R in Primary Mediastinal B-Cell Lymphoma; Analysis of End of Therapy FDG-PET and Outcome (2016) (6)
Human T-lymphotropic virus type I DNA in spinal cord of tropical spastic paraparesis with concomitant human T-lymphotropic virus type I-negative Hodgkin's disease. (1994) (6)
Clonally unrelated Hodgkin's disease following autologous stem cell transplant for B‐cell lymphoma (2002) (6)
[MALT lymphoma of the larynx]. (2000) (6)
Relationship of classification to biologic behavior of non-Hodgkin's lymphomas. (1986) (6)
Follicular lymphomas: a tapestry of common and contrasting threads (2013) (6)
Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma. (1981) (6)
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T-cells in PTCL-NOS. (2022) (6)
Immune markers in the diagnosis of malignant lymphomas. (1988) (6)
A new immunostain algorithm improves the classification of diffuse large B-cell lymphoma into prognostically significant subgroups (2008) (6)
Epstein-Barr Virus–Positive Systemic T-Lymphoproliferative Disorders and Related Lymphoproliferations of Childhood (2011) (6)
XII. Gray zone lymphomas: a biological experiment, and a challenge for diagnosis and management (2011) (6)
An anaplastic T-cell lymphoma mimicking classical Hodgkin lymphoma. (2018) (6)
Human t‐cell leukemia virus‐i and hematologic malignancies in panama (1989) (6)
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma (2021) (6)
Neutrophil and Eosinophil Extracellular Traps in Hodgkin Lymphoma (2021) (6)
A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma (2020) (5)
Hepatosplenic T-cell lymphoma of alphabeta lineage. (2001) (5)
Normal Lymphoid Organs and Tissues (2011) (5)
HYPOTHESIS: FOLLICULAR LYMPHOMAS – ARE THEY BENIGN TUMORS OF THE LYMPHOID SYSTEM? (1982) (5)
Next-generation sequencing–based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL (2021) (5)
Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma (2022) (5)
Taking gray zone lymphomas out of the shadows. (2021) (5)
(cid:103)(cid:100) T-Cell Lymphoma of the Skin A Clinical, Microscopic, and Molecular Study (2000) (5)
Iterative Germinal Center Re-Entries of Memory B-Cells with t(14;18) Translocation and Early Steps of Follicular Lymphoma Progression (2012) (5)
Hodgkin's disease coexistent with plasma cell dyscrasia. (1992) (5)
Epstein-Barr Virus-negative Marginal Zone Lymphoma as an Uncommon Form of Monomorphic Posttransplant Lymphoproliferative Disorder (2020) (5)
CHARACTERIZATION OF THE GENETIC LANDSCAPE OF HIGH‐GRADE B‐CELL LYMPHOMA, NOS – AN LLMPP PROJECT (2021) (5)
Introduction: Hodgkin's lymphoma--pathology, pathogenesis, and treatment. (1999) (5)
Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues : Report of the Clinical Advisory Committee Meeting — Airlie House , Virginia , November 1997 By (1999) (5)
Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas (2018) (5)
T-cell and NK-cell neoplasms of the gastrointestinal tract – recurrent themes, but clinical and biological distinctions exist (2020) (5)
Response during radiotherapy may be associated with outcome in mediastinal Hodgkin's disease. (1998) (5)
CORRESPONDENCE CASE REPORT Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gd T cell lymphoma (1997) (5)
Is Lymphocytic Interstitial Pneumonitis an Early Stage of MALT Lymphoma in HIV-Infected Pediatric Patients?: 151 (1997) (5)
What is anaplastic large cell lymphoma? (2004) (4)
Eleven-Year Follow-up of Idiotype Vaccine and DA-EPOCH-Rituximab in Untreated Mantle Cell Lymphoma: Correlation of Survival with Idiotype Immune Response (2011) (4)
Genomic characterization of diffuse large B-cell lymphoma transformation of nodular lymphocyte-predominant Hodgkin lymphoma (2020) (4)
Gray zone lymphomas : a biological experiment , and a challenge for diagnosis and management (2011) (4)
Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab. (2011) (4)
Point mutations and genomic deletions in Cyclin D1 create stable truncated mRNAs that are associated with increased proliferation rate and shorter survival in mantle cell lymphoma Lymphoma/Leukemia Molecular Profiling (2007) (4)
CNS Infiltration: A Complication of Diffuse Lymphomas (1979) (4)
Age related EBV associated lymphoproliferative disorder – a spectrum of reactive lymphoid hyperplasia and lymphoma : The Western experience (2011) (4)
Lymphdx: A Custom Microarray for Molecular Diagnosis and Prognosis in Non-Hodgkin Lymphoma. (2004) (4)
Constitutive Activation of AKT Contributes to the Pathogenesis and Survival of Blastoid Variants of Mantle Cell Lymphoma. (2005) (4)
Comparative Study of Circulating Tumor DNA and Computerized Tomography Monitoring in Untreated Diffuse Large B-Cell Lymphoma (2015) (4)
Immunologic markers of non-Hodgkin's lymphomas. (1978) (4)
Surface light chain phenotype in indolent lymphomas: Lack of prognostic significance (1990) (4)
A Multi-scale, Multiomic Atlas of Human Normal and Follicular Lymphoma Lymph Nodes (2022) (4)
Use of the Polymerase Chain Reaction Technique to Determine c‐myc Expression in Follicular Center Cell Lymphoma (1996) (4)
Adrenal Hodgkin lymphoma (2010) (4)
Phase 1 Study of Escalating Doses of Ibrutinib and Temozolomide, Etoposide, Liposomal Doxorubicin, Dexamethasone, Rituximab (TEDDI-R) with Isavuconazole for Relapsed and Refractory Primary CNS Lymphoma (2020) (4)
EBV driven natural killer cell disease of the central nervous system presenting as subacute cognitive decline (2017) (4)
IL-31 Receptor Alpha Expression in Epidermal Keratinocytes Is Modulated by Cell Differentiation and Interferon Gamma (2009) (4)
Phase 2 Study of Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-Hodgkin Lymphomas (2021) (4)
Human Herpes Virus 6 (HHV-6)–associated Lymphadenitis: Pitfalls in Diagnosis in Benign and Malignant Settings (2018) (4)
Good outcome of AIDS-related Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) with abbreviated cycles of EPOCH-rituximab (2009) (4)
Delta-positive T-cell lymphoma that produces interferon gamma. (1992) (4)
Salivary gland lymphadenopathies associated with AIDS: reply. (1988) (3)
Accurate Diagnosis of Aggressive B Cell Non-Hodgkin Lymphomas Using Gene Expression Profiling of Formalin-Fixed, Paraffin-Embedded Tissues (2014) (3)
Safety , efficacy , and pharmacokinetics / pharmacodynamics of daclizumab ( anti-CD 25 ) in patients with adult T-cell leukemia / lymphoma (2015) (3)
Response to “The WHO classification of haematolymphoid tumours” (Editorial) (2022) (3)
Persistent indolent pancolonic marginal zone lymphoma of MALT-type with plasmacytic differentiation – A rare post-transplant lymphoma? (2017) (3)
Gene expression distinguishes Burkitt lymphoma from other aggressive lymphomas and identifies patients who are highly curable with intensive chemotherapeutic regimens. (2005) (3)
TAFRO syndrome: A case report and review of the literature. (2017) (3)
A novel approach for characterization of KSHV‐associated multicentric Castleman disease from effusions (2022) (3)
Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Analysis (2019) (3)
Aberrant Immunoglobulin Class Switch Recombination and Switch Translocations in Activated B Cell-Like Diffuse Large B-Cell Lymphoma. (2006) (3)
Follicular lymphoma and marginal zone lymphoma: how many diseases? (2022) (3)
DNA Sequencing-Based Monitoring Of Serum Predicts Clinical Relapse Before CT Imaging in Diffuse Large B-Cell Lymphoma (2013) (3)
An enhanced surveillance program for adult T-cell leukemia in central Brooklyn. (1994) (3)
Avidin-biotin labeling of cellular antigens in cryostat-sectioned tissue. (1994) (3)
Chromosome 1p terminal deletion and loss of chromosome 17p and 16p are common findings in nasal NK/T cell lymphoma by comparative genomic hybridization (1998) (3)
t(14;18)-positive B cells: is it seed or soil? (2018) (3)
End-of-Treatment CT and Serial FDG-PET Imaging to Assess Residual Disease in Primary Mediastinal B-Cell Lymphoma (2017) (3)
Lymphoproliferative disorder of fetal origin presenting as oligohydramnios. (1999) (3)
Hodgkin Lymphoma Variant of Richter Transformation: Morphology, EBV Status, Clonality and Survival Analysis a Retrospective Study of 77 Patients (2015) (3)
Late-Onset Severe Chronic Active EBV in a Patient for Five Years with Mutations in STXBP2 (MUNC18-2) and PRF1 (Perforin 1) (2015) (3)
CCND1 Genomic Rearrangement as a Secondary Event in High Grade B-Cell Lymphoma (2020) (3)
Bilateral adrenal hemorrhage and adrenal insufficiency in a patient with lymphomatous adrenal infiltration following administration of a fusion toxin (DAB486 interleukin-2). (1994) (3)
A Prospective Study of Clonal Evolution in Follicular Lymphoma: Circulating Tumor DNA Correlates with Overall Tumor Burden and Fluctuates over Time without Therapy (2021) (3)
Evolution in the definition and diagnosis of the Hodgkin lymphomas and related entities (2022) (3)
Extraoular muscle palsies in subcutaneous panniculitis-like T-cell lymphoma. (2003) (3)
Phase 1b/2 Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory and Untreated Mantle Cell Lymphoma: Safety, Efficacy, and Molecular Analysis (2021) (2)
Molecular Diagnostics (2003) (2)
Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma. (2008) (2)
Uncommon Presentations of Malignancies CASE 1. EXTRAOCULAR MUSCLE PALSIES IN SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA (2003) (2)
Molecular Subgroups of Peripheral T-Cell Lymphoma Evolve By Distinct Genetic Pathways (2016) (2)
Clinicopathologic Characterization of Cyclin D1-Negative Mantle Cell Lymphoma (2012) (2)
Centralized review offers promise for the clinician, the pathologist, and the patient with newly diagnosed lymphoma. (2011) (2)
Induction of complement receptors in human cell lines derived from undifferentiated lymphomas. (1981) (2)
The Addition of Rituximab to Dose-Adjusted EPOCH with HAART Suspension Is Highly Effective and Tolerable in AIDS-Related Lymphoma (ARL) and Allows the Delivery of Abbreviated Chemotherapy. (2005) (2)
subtypes of diffuse large B-cell lymphoma Differential efficacy of bortezomib plus chemotherapy within molecular (2013) (2)
Differential diagnosis of CD3+, CD56+ T-cell leukemias. (1995) (2)
NIH conference. A multidisciplinary approach to non-hodgkin's lymphomas. (1981) (2)
Association of idiotype vaccine-induced T-cell response with improved survival and time-to-next treatment (TTNT) in untreated mantle cell lymphoma (MCL). (2012) (2)
Diffuse Large B-Cell Lymphoma Subgroups Have Distinct Genetic Profiles that Influence Tumor Biology and Improve Gene Expression-Based Survival Prediction for the Lymphoma/Leukemia Molecular Profiling Project (2005) (2)
Morphologic, immunologic and genetic features of peripheral T cell lymphomas (unspecified category) (1999) (2)
Langerhans Cell Histiocytosis, Non-Langerhans histiocytosis and concurrent Papillary Thyroid Carcinoma with BRAF V600E mutations: A case report and literature review (2019) (2)
World Health Organization Classification of Hematologic Malignancies (2008) (2)
Yttrium-90 Radiolabeled Daclizumab, An Anti-CD25 Monoclonal Antibody, Provides Effective Therapy for Refractory and Relapsed Hodgkin's Lymphoma, (2011) (2)
Epidemiology of HTLV-associated leukemia. (1983) (2)
Authors' Reply: Pulmonary Lymphoma in an Immunocompromised Host (1996) (2)
CD30+ large B cell lymphoma with anaplastic features and complete loss of B cell marker expression arising from follicular lymphoma (2019) (2)
PHASE 1B STUDY OF ViPOR (VENETOCLAX, IBRUTINIB, PREDNISONE, OBINUTUZUMAB, LENALIDOMIDE) IN RELAPSED/REFRACTORY B‐CELL LYMPHOMA: SAFETY, EFFICACY AND MOLECULAR ANALYSIS (2019) (2)
Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain (2019) (2)
Protocol for the examination of specimens from patients with hematopoietic neoplasms of the ocular adnexa. (2010) (2)
Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142) (2020) (2)
Avidin-biotin labeling of cellular antigens in cryostat-sectioned tissue. (1999) (2)
Radiation-Sparing Treatment of HIV-Related Primary Central Nervous System Lymphoma with Antiretroviral Therapy, Rituximab and High-Dose Methotrexate (2018) (2)
Phase 2 Study of Acalabrutinib Window Prior to Frontline Therapy in Untreated Aggressive B-Cell Lymphoma: Preliminary Results and Correlatives of Response to Acalabrutinib (2021) (2)
The serine protease granzyme M is preferentially expressed in NK-cell, γδ T-cell, and intestinal T-cell lymphomas: evidence of origin from lymphocytes involved in innate immunity (2002) (2)
Clinical, Immunologic, and Virologic Findings in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Lymphomas Suggest KSHV-Associated Inflammatory Syndromes Contribute to Symptoms and Disease Pathogenesis. (2012) (1)
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial. (2023) (1)
A Phase I/II Study of a Hybrid Schedule of Flavopiridol in Relapsed/Refractory Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma (2010) (1)
Functionality of lung type II NKT cells developing in CD1d−/− animals (2017) (1)
using gene expression in formalin-fixed paraffin-embedded tissue Determining cell-of-origin subtypes of diffuse large B-cell lymphoma (2014) (1)
Molecular insights into the pathogenesis of follicular lymphoma (2021) (1)
IDENTIFICATION OF Fc AND COMPLEMENT RECEPTORS IN TISSUE SECTIONS (1981) (1)
T-cell leukemia/lymphoma The human T-cell leukemia/lymphoma virus associated with American adult (2011) (1)
Diffuse Small Noncleaved-Cell, Non-Burkitt's Lymphoma in Adults (2016) (1)
Early Results of a Clinical Trial Using Targeted Oncolytic Virotherapy in Kaposi Sarcoma Herpes Virus (KSHV) Associated Multicentric Castleman’s Disease (MCD). (2007) (1)
PULMONARY LYMPHOMA IN AN IMMUNOCOMPROMISED HOT. AUTHORS' REPLY (1996) (1)
The Revised Who Classification of Lymphomas – What Has Changed for The Pathologist and Clinician (2019) (1)
The outcome of ALK positive and ALK negative anaplastic large cell lymphoma (ALCL) following DA-EPOCH. (2015) (1)
Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP (2010) (1)
The Genomic Landscape of Plasmablastic Lymphoma (PBL) - an L.L.M.P.P. Project (2021) (1)
Genomic Characterization of Diffuse Large B-Cell Lymphoma Transformation from Nodular Lymphocyte Predominant Hodgkin Lymphoma (2019) (1)
18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome. (2019) (1)
lymphoma by immunohistochemistry using a tissue microarray Confirmation of the molecular classification of diffuse large B-cell (2013) (1)
Calcification in benign non-functioning adrenal adenoma. Report of a case with selective adrenal arteriogram. (1972) (1)
Immunologic phenotypes of non-Hodgkin’s lymphomas: Correlation with morphology and function (1985) (1)
disease: a 28-year experience in the United States Characterization and treatment of chronic active Epstein-Barr virus (2011) (1)
Anaplastic large-cell lymphoma (ALK-negative)-related heart failure and recurrence after heart transplantation. (2020) (1)
Lymphoid hyperplasia with atypical dendritic/Langerhans cell proliferation mimicking Hodgkin lymphoma (2019) (1)
Determining Cell-Of-Origin Subtypes In Diffuse Large B-Cell Lymphoma Using Gene Expression Profiling On Formalin-Fixed Paraffin-Embedded Tissue – An L.L.M.P.P. Project (2013) (1)
Mutation Spectrum of Transformed Nodular Lymphocyte Predominant Hodgkin Lymphoma and Comparison with De Novo Diffuse Large B-Cell Lymphoma (2017) (1)
Treatment Outcomes and Prognostic Factors in 40 Patients with Primary Effusion Lymphoma (2021) (1)
Lymphoma Nomenclature ‐ What's in a name? (2022) (1)
Treatment and biology of lymphomatoid granulomatosis (2007) (1)
Clinicopathologic and Molecular Characterization of Epstein-Barr Virus–positive Plasmacytoma (2022) (1)
A Prospective Multicenter Phase 2 Study of Dose-Adjusted-EPOCH-R in Untreated MYC-Rearranged Aggressive B-cell Lymphoma (2019) (1)
Methylation Profiling of Mediastinal Gray Zone Lymphoma Reveals a Distinctive Signature with Elements Shared by Classical Hodgkin's Lymphoma and Mediastinal Large B-Cell Lymphoma (2010) (1)
Comprar Hematopathology (Online And Print) 2nd Ed. | Elaine Sarkin Jaffe | 9780323296137 | Elsevier España (2016) (1)
KEY GENETIC AND MOLECULAR ABERRATIONS IDENTIFIED IN BOTH ADULT AND EBV‐POSITIVE BURKITT LYMPHOMA PATIENTS (2021) (1)
Burkitt Lymphoma Genome Sequencing Project (BLGSP): Introduction (2016) (1)
Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon. (2013) (1)
Burkitt Lymphoma Genome Sequencing Project (BLGSP): Integrative Genomic and Transcriptomic Characterization of Burkitt Lymphoma (2017) (1)
The transcription factor CCAAT/enhancer binding protein (C/EBP)beta is constitutively expressed in ALK-positive anaplastic large cell lymphomas (ALCL), and is dependent upon NPM-ALK kinase activity (2006) (1)
Pediatric Hodgkin and Non-Hodgkin Lymphomas (2016) (1)
Castleman disease spectrum. (2020) (1)
Molecular Signatures Implicate Innate Immune Cells, Fibrosis, and Angiogenesis in Survival Following R-CHOP Treatment of Diffuse Large B Cell Lymphoma (2008) (1)
Molecular Assay for the Proliferation Signature in Mantle Cell Lymphoma Applicable to Formalin-Fixed Paraf fi n-Embedded Biopsies (2017) (1)
mantle cell lymphoma - D1 CCND2 rearrangements are the most frequent genetic events in cyclin (2013) (1)
Histiocytoses converge through common pathways. (2022) (1)
A collection of memories of Professor Karl Lennert (2013) (1)
The interrelationship between Hodgkin's disease (HD) and non-Hodgkin's lymphomas (NHL) (1995) (1)
Primr kutanes Gamma/Delta‐TZell‐Lymphom (2009) (1)
variants of mantle cell lymphomas ( MCL ) : implications for pathogenesis protein by cyclin D 1 in typical and blasticKip 1 Sequestration of p 27 ( 795 articles (2002) (1)
Nasal/nasal type NK/T cell lymphoma (angiocentric lymphoma) and lymphomatoid granulomatosis (1999) (1)
Commentary on “Pathologic Diagnosis of Mantle Cell Lymphoma” (2000) (1)
A Phase II Trial of Alemtuzumab (Campath) with DA-EPOCH-R in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma (2012) (1)
Evolution in the Definition of Follicular Lymphoma and Diffuse Large B-Cell Lymphoma: A Model for the Future of Personalized Medicine (2022) (1)
The diversity of p53/p2l transactivation phenotype of p53 signaling pathway and their relationship to TP53 gene mutation and clinical outcome in diffuse large B-Cell lymphoma (DLBCL) (2007) (1)
Bortezomib plus DA-EPOCH-rituximab followed by bortezomib maintenance versus observation in previously untreated mantle cell lymphoma (MCL). (2011) (1)
Identification of crystalline deposits. (1980) (1)
THE MUTATIONAL LANDSCAPE OF DOUBLE/TRIPLE‐HIT HIGH‐GRADE B‐CELL LYMPHOMA WITH BCL2 REARRANGEMENT (DH/TH‐ BCL2 ) – AN LLMPP PROJECT (2021) (1)
Cell-of-Origin Subtype Classification of Diffuse Large B-Cell Lymphoma Using the Lymph2Cx Assay Retains Relevance in the Context of BCL2 and MYC Expression Status (2014) (1)
Distinctive Patterns of BCL6 Molecular Alterations in Different Subsets of Diffuse Large B-Cell Lymphoma and Their Functional Consequences. (2005) (1)
Chapter 73 – The Pathologic Basis for the Classification of Non-Hodgkin and Hodgkin Lymphomas (2018) (1)
Cutaneous lymphomas: it's location, location, location (2005) (1)
Recurrent Oncogenic Mutations in CCND3 in Aggressive Lymphomas (2011) (1)
Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT) (2022) (1)
Preliminary Results from a Phase II Study of Response-Adapted Therapy with Copanlisib and Rituximab for Untreated Follicular Lymphoma (2020) (1)
Scientific category : LYMPHOID NEOPLASIA Title : A new biological prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma (2012) (1)
Chapter 4 B-cell and classical Hodgkin lymphomas associated with immunodeficiency (2017) (1)
B-Cell Prolymphocytic Leukemia With t(8;14) Translocation (2012) (1)
CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma. (2007) (1)
18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome. (2019) (1)
infection of B lymphocytes and response to interferon-alpha 2b Association of lymphomatoid granulomatosis with Epstein-Barr viral (2011) (0)
Comprar Hematopathology. Expert Consult - Online and Print | Elaine Sarkin Jaffe | 9780721600406 | Saunders (2010) (0)
Genetic Abnormalities Involved in the Development and Progression of Follicular Lymphoma. (2008) (0)
Efficacy of alemtuzumab (ALZ) in combination with dose-adjusted EPOCH (DA-EPOCH) in untreated nodal peripheral T-cell lymphoma (PTCL). (2012) (0)
State of the Art on T-cell lymphomas: the Pathogenesis (2009) (0)
Mutational Status of Chronic Lymphocytic Leukemia (CLL) Determines Clonlal Evolution in Classical Hodgkin’s Lymphoma Variant of Richter’s Transformation. (2005) (0)
hematopoietic cell transplantation Risk factors for lymphoproliferative disorders after allogeneic (2013) (0)
Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma. (2022) (0)
Phase II study of EPOCH infusional chemotherapy in relapsed or refractory Hodgkin's lymphoma (HL). A report on toxicity, efficacy and prognostic indicators of outcome. (2004) (0)
Abstract LB-281: Hodgkin Lymphoma requires stabilized NIK and constitutive RelB expression for survival (2012) (0)
Rapid, de novo development of isolated intracranial rosai-dorfman disease: A case report (2015) (0)
Whole-Body Positron Emission Tomography (PET) Using 2-18Fluoro-2-Deoxy-D-Glucose (FDG) for Monitoring Lymphadenopathy in Autoimmune Lymphoproliferative Syndrome (ALPS). (2004) (0)
variants of mantle cell lymphoma (MCL): implications for pathogenesis Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic (2013) (0)
INTEGRATIVE MUTATIONAL ANALYSIS OF PEDIATRIC‐TYPE FOLLICULAR LYMPHOMA REVEALS TNFRSF14 AND MAP2K1 AS THE MOST FREQUENTLY MUTATED GENES (2017) (0)
Pseudolymphoma of the parapharyngeal space (1991) (0)
Diversity of Immunological Phenotypes of Lymphoblastic Lymphoma 1 (2006) (0)
The Functional Immunophenotypic Profile of Kikuchi Fujimoto Disease: Comparison with Systemic Lupus Erythematosus (2022) (0)
PEDIATRIC NODAL MARGINAL ZONE LYMPHOMA AND PEDIATRIC-TYPE FOLLICULAR LYMPHOMA SHARE A COMMON MOLECULAR PROFILE (2022) (0)
Phase I/II study of Yttrium-90 labeled humanized anti-Tac (HAT) monoclonal antibody and calcium DTPA in adult T-cell leukemia/lymphoma (ATL) (2006) (0)
Case 41-1981: malignant lymphoma with hypercalcemia. (1982) (0)
Periodic fever with atypical dyshidrosis--quiz case. (2004) (0)
DNA Methylation-Based Burkitt Lymphoma Epitypes Have Distinct Molecular and Clinical Features (2022) (0)
Loss of CIITA and MHC Class II Expression in Diffuse Large B-Cell Lymphoma Is Not Explained by Methylation of CIITA Promoters III and IV. (2008) (0)
Inmunoglobulin light chain enhancer hijacking activates CCND2 and CCND3 in cyclin D1-negative mantle cell lymphoma (2018) (0)
Notch1/2 Mutations Are Recurrently Found in Cyclin D1-Negative Sox11-Positive Mantle Cell Lymphoma (2015) (0)
CD 30 ANTIGEN EXPRESSION. AUTHOR'S REPLY (1991) (0)
Classification of the Peripheral T‐cell Lymphomas (2021) (0)
Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts (2018) (0)
THE TOPOLOGY OF MYC REARRANGEMENTS IN DOUBLE‐HIT LYMPHOMA IS CONSTRAINED BY THE PRECEDING IGH ‐BCL2 REARRANGEMENT – AN LLMPP PROJECT (2021) (0)
Hematopathology. Expert Consult - Online and Print (2010) (0)
An Isolated Mesenteric Presentation of a Nodal Peripheral T Cell Lymphoma with T Follicular Helper Cell Phenotype (2022) (0)
‘A novel approach for characterisation of KSHV‐associated multicentric Castleman disease from effusions’: Response (2023) (0)
Hepatosplenic Tce l l Lymphoma : A Distinct Clinicopathologic Entity of Cytotoxic yS T-cel l Origin (0)
Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorder (2022) (0)
Cutaneous Langerhans Cell Sarcoma Associated with Mediastinal T‐Cell Acute Lymphoblastic Lymphoma: Clonally Related Neoplasms (2008) (0)
Whole Exome Sequencing Defines the Genetic Differences Between Pediatric and Adult Follicular Lymphoma (2015) (0)
-negative high-grade B-cell lymphomas resembling Burkitt lymphoma MYC A recurrent 11q aberration pattern characterizes a subset of (2014) (0)
Core biopsy for lymphoma diagnosis? A needling prospect. (2022) (0)
Chromosomal aberrations in gray zone lymphomas (2011) (0)
Integrative Analysis of 1001 Diffuse Large B Cell Lymphoma Identifies Novel Oncogenic Roles for Rhoa (2017) (0)
Phase 2 Study of Alemtuzumab Added to Dose-Adjusted EPOCH-R in Relapsed and Refractory Aggressive B-Cell Lymphomas (2019) (0)
IL-4 Expression and Constitutive Activation of Erk Signaling In Vivo in Follicular Lymphoma. (2007) (0)
Response-Adapted Therapy in HIV-Associated Diffuse Large B-Cell Lymphoma: Updated Results of a Prospective Phase II Study of Short-Course-EPOCH-RR (2019) (0)
Abstract 4622: Characterization of sulfatide reactive type II NKT cells from mouse lung (2017) (0)
Abstract 1630: Cell-cell fusion in vivo transfers genes for human malignancy, metastasis, and the donor tumors’ organoid phenotype to stromal hamster cells. (2013) (0)
Hodgkin Lymphomas – Historical Background And Evolution (2019) (0)
Introduction to Diagnostic Problems in Angioimmunoblastic Lymphadenopathy (1991) (0)
Principles of Classification of Lymphoid Neoplasms (2011) (0)
Accurate Classification of Diffuse Large B Cell Lymphoma Into Germinal Center and Activated B Cell Subtypes Using a Nuclease Protection Assay On Formalin Fixed Paraffin Embedded Tissue: A Study From the Lymphoma and Leukemia Molecular Profiling Project. (2009) (0)
Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL). (2009) (0)
lymphoproliferative Disorders (LPD) Associated With Immune Deficiency (2019) (0)
The Landscape of Cutaneous Lymphomas in 2016, An Introduction. (2017) (0)
Morphologic, immunologic and genetic features of HTLV-1-positive adult T cell lymphoma/leukemia (1999) (0)
lymphocytes involved in innate immunity T-cell, and intestinal T-cell lymphomas: evidence of origin from δ γ The serine protease granzyme M is preferentially expressed in NK-cell, (2013) (0)
Peripheral T-Cell Neoplasms – Current Classification And Differential Diagnosis (2019) (0)
[Diarrhea, adenopathies, and pulmonary lesions in a 42-year-old male with common variable immunodeficiency]. (1994) (0)
immunodeficiency virus-positive homosexual patient Development of a second clonally discrete Burkitt's lymphoma in a human (2012) (0)
Plasma Cell Myeloma and Plasma Cell Disorders (2017) (0)
Function of IL2 receptor beta subunit in normal and leukemic thymocytes and LGL (1987) (0)
Abbreviated Treatment with EPOCH-Rituximab and HAART Suspension Is Highly Effective in AIDS-Related Lymphoma (ARL). (2006) (0)
AN INCREASED RISK OF B-CELL LYMPHOMAS IN AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME (ALPS) (1999) (0)
HLA antigens in angioimmunoblastic lymphadenopathy. (1985) (0)
Quantitative Baseline Circulating Tumor DNA Levels Correlate with GM-CSF Response to Idiotype Vaccine in Untreated Mantle Cell Lymphoma (2016) (0)
Chapter 4 Molecular Diagnosis of Burkitt lymphoma (2019) (0)
Paraffin-Embedded Tissues Nuclease Protection Assay on Formalin-Fixed , into Germinal Center and Activated B-Cell Subtypes Using a Accurate Classification of Diffuse Large B-Cell Lymphoma (2011) (0)
undefined autoimmune lymphoproliferative syndrome mutations are common in patients with genetically FAS Somatic (2012) (0)
Lymphohistiocytosis Unusual Immunophenotype of CD8+ T-cells in Familial Hemophagocytic (2013) (0)
malignancies (editorial; comment) Classification of natural killer (NK) cell and NK-like T-cell (2013) (0)
Book Reviews (2002) (0)
EBV-associated inflammatory pseudotumor presenting as a colonic mass (2015) (0)
High Microvascular Density Correlates with Poor Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab Plus Chemotherapy (R-CT). (2009) (0)
Integration and Iteration: Using Advanced, High-Content Imaging and Single-Cell Gene Expression Analysis to Uncover Unique Aspects of Follicular Lymphoma Biology (2020) (0)
Introduction to Hematologic Malignancies (2017) (0)
Malignancies of the Immune System: Use of Immunologic and Molecular Tumor Markers in Classification and Diagnostics (2006) (0)
Dural Marginal Zone Lymphoma With Extensive Crystal Storing Histiocytosis: Spotting the Zebra Among the Horses. (2022) (0)
Lymphocyte-rich classical Hodgkin's disease (LRCHD) : Clinical relevance of a provisional entity (1997) (0)
Cutaneous Lymphomas, Pseudolymphomas, and Related Disorders (1985) (0)
Periodic Fever with Atypical Dyshidrosis (2004) (0)
Genome-wide miRNAprofiling of mantle cell lymphoma reveals a distinctsubgroup with poor prognosis (2019) (0)
IL-21 e Driven Neoplasms in SJL Mice Mimic Some Key Features of Human Angioimmunoblastic T-Cell Lymphoma (2015) (0)
Disorders of the lymph nodes and related organs : based on the proceedings of the fifty-eighth Annual Anatomic Pathology Slide Seminar of the American Society of Clinical Pathologists : October 15 and 16, 1992, Las Vegas, Nevada (1994) (0)
University of Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics (2012) (0)
survival in mantle cell lymphoma mRNAs that are associated with increased proliferation rate and shorter Point mutations and genomic deletions in Cyclin D1 create stable truncated (2013) (0)
Novel Genetic Subgroups Inform on Shared Pathobiology within Adult and Pediatric Burkitt Lymphoma (2021) (0)
Immunotherapy of Lymphomatoid Granulomatosis (2022) (0)
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in Relapsed and Refractory Follicular Lymphoma: Analysis of Safety, Efficacy, and Minimal Residual Disease (2022) (0)
Hodgkins and large-cell lymphoma: a response to Dr. Whittaker. (1989) (0)
Comparison between combination chemotherapy and total body irradiation plus combination chemotherapy in non-Hodgkin's lymphoma. [Effectiveness and complications] (1979) (0)
Advances in the Classification of Myeloid and Lymphoid Neoplasms (2022) (0)
The diversity of p53/p21 transactivation phenotype of p53 signaling pathway and their relationship to TP53 gene mutation and clinical outcome in diffuse large B-cell lymphoma (DLBCL) (2007) (0)
Superiority of ProMACE-CytaBOM Over ProMACE-MOPP in the Treatment of Advanced Diffuse Aggressive Lymphoma (2016) (0)
Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH. (2007) (0)
77 – Lymphomas including Hodgkin lymphoma (2008) (0)
Genetic Abnormalities in Follicular Lymphoma and Transformed Follicular Lymphoma. (2012) (0)
Scientific category: Lymphoid neoplasia Title: Indolent T-cell lymphoproliferative disease of the gastrointestinal tract Authors: (2013) (0)
Predictor of survival Diffuse large B-cell lymphoma (2009) (0)
COPY NUMBER VARIATION ANALYSIS IDENTIFIES DISTINCT GENOMIC FEATURES IN ADULT BURKITT LYMPHOMA (2021) (0)
of mantle cell lymphoma Constitutive activation of Akt contributes to the pathogenesis and survival (2013) (0)
CSF1R/CD115 is a Helpful Marker for the Distinction of Florid Dermatopathic Lymphadenopathy From Langerhans Cell Neoplasms. (2023) (0)
cancer cell yibin (2016) (0)
clone sarcomas: evidence for transdifferentiation of the follicular lymphoma Clonally related follicular lymphomas and histiocytic/dendritic cell (2013) (0)
New Approaches to the Diagnosis and Classification of the Non-Hodgkin’s Lymphomas (1980) (0)
SUMMARY OF CLINICOPATHOLOGIC DATA Biopsy Site Biopsy Site Case (2015) (0)
MOLECULAR CLASSIFICATION OF PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA USING FORMALIN‐FIXED, PARAFFIN‐EMBEDDED TISSUE SPECIMENS – AN LLMPP PROJECT (2017) (0)
at the 40th Annual American Society of Hematology Meeting, December 7, part Sarcoma-Associated Herpesvirus-Encoded Interleukin-6 : Presented in Angiogenesis and Hematopoiesis Induced by Kaposi's (2013) (0)
Reply to M. Romero et al. (2020) (0)
T-cell and natural killer-cell lymphomas An update based on the 2008 WHO classification (2009) (0)
A window into cutaneous adult T-cell leukemia/lymphoma. (2015) (0)
Technical Advance Analysis of T Cell Receptor-y Gene Rearrangements by Denaturing Gradient Gel Electrophoresis of GO-Clamped Polymerase Chain Reaction Products Correlation with Tumor-Specific Sequences (2007) (0)
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile (2022) (0)
High Cyclin D1 Expression Is Associated with Increased Proliferation Rate and Decreased Survival in Mantle Cell Lymphoma (MCL) and Is Caused by Genomic Deletions and Mutations that Enhance Stability of Cyclin D1 mRNA. (2004) (0)
MYC Translocations and Expression Are Clinically Important in R-CHOP Treated Patients with De Novo DLBCL. (2009) (0)
GENOME WIDE‐ANALYSIS OF T(14;18)‐NEGATIVE FOLLICULAR LYMPHOMA (2019) (0)
LYMPHOID NEOPLASIA CCND2 rearrangements are the most frequent genetic events in cyclin D1 (cid:1) mantle cell lymphoma (2013) (0)
Origin T- and Null-Cell Type and Hodgkin's Disease: Evidence for Distinct Cellular Cytotoxic Cell Antigen Expression in Anaplastic Large Cell Lymphomas of (2013) (0)
subgroups in peripheral T-cell lymphoma Gene expression signatures delineate biological and prognostic (2014) (0)
‘ ‘ focus on . . . ’ ’ session : profiling and prognosis (2008) (0)
Can multiple myeloma become a curable disease (2011) (0)
A Constitutivly Active NFkB Non Canonical Pathway Is Maintained by RelB Repression of TRAF2 to Prevent Autophagy-Mediated Cell Death in Hodgkin Lymphomas (2011) (0)
Unusual immunophenotype of CD8 (cid:1) T cells in familial hemophagocytic lymphohistiocytosis (2004) (0)
Letter: Surface characteristics of Hodgkin's lymphoma cells. (1974) (0)
New M alignant D iseases A fter A llogeneic M arrow Transplantation f or C hildhood A cute L eukemia (2000) (0)
Involvement of CDKN2 @ ) and p15â€(cid:157)4â€(cid:157)/MTS2in Human Leukemias and Lymphomas (2006) (0)
Abstract 1056: Xenograft-associated B cell lymphoproliferative disease (XABLD) as a surrogate model to study Epstein-Barr virus (EBV) driven B cell Diseases (2019) (0)
capture microdissection In situ localization of follicular lymphoma: description and analysis by laser (2013) (0)
Constipated plasma cells in extranodal marginal zone lymphoma of the lung. (2019) (0)
Preliminary results of a clinical trial using chemo-immunotherapy in Kaposi sarcoma herpesvirus (KSHV)-associated multicentric Castleman’s disease (MCD) (2008) (0)
Borderlands between pathological entities: composite lymphomas (2010) (0)
neoplasms Molecular analysis of the BCL-3 locus at chromosome 17 q 22 in B-cell (2003) (0)
Phase 1 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide in Combination with Polatuzumab (ViPOR-P) in Relapsed/Refractory B-Cell Lymphoma: Preliminary Analysis of Safety and Efficacy (2022) (0)
Splenic diffuse red pulp small B-cell lymphoma with cyclin D3 expression. (2022) (0)
Special Report International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease (2019) (0)
Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target (2016) (0)
Gray Zone Lymphoma (GZL) with Features Intermediate between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): A Pathologic Consensus Study with Patient Outcomes and Prognostication across 15 North American Centers (2017) (0)
lymphomas of B-cell origin Distribution of complement receptor subtypes in non-Hodgkin's (2011) (0)
O19 Clinicopathologic analisis and survival of 151 patients with T- and NK-cell lymphomas at the Federal Research Hematology Center of Russian Academy of Medical Sciences: a retrospective study (2007) (0)
Genome-Wide Expression Profiling Predicts Treatment Outcome in Classical Hodgkin Lymphoma (2008) (0)
Marginal Zone B-Cell Lymphoma With Monocytoid B-Cell Lymphocytes in Pediatric Patients Without Immunodeficiency (2016) (0)
Avidin-biotin labeling of cellular antigens in cryostat-sectioned tissue. (2010) (0)
A novel case of gamma-delta T-cell lymphoma expressing CD4, recapitulating a stage of gamma-delta T-cell development. (2022) (0)
Gray Zone Lymphoma (GZL) with Features Intermediate Between Diffuse Large B-Cell Lymphoma (DLBCL) and Classical Hodgkin Lymphoma (cHL): Pathologic Classification and Clinical Outcomes from a Multicenter Consensus Study (2016) (0)
International Workshop lymphoproliferative syndrome (ALPS): report from the 2009 NIH Revised diagnostic criteria and classification for the autoimmune (2010) (0)
DISCOVERY OF RECURRENT ONCOGENIC MUTATIONS IN LYMPHOMA BY RNA-SEQ (2011) (0)
List of Contributors (2019) (0)
16 – WHO Classification of Hematologic Malignancies (2014) (0)
Mature Nodal and Extranodal T-Cell and NK-Cell Lymphoma (2009) (0)
David York Mason (1941-2008). Antibody wizard and a founder of modern hemopathology (2008) (0)
Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD) (2009) (0)
lymphoma IL-4 protein expression and basal activation of Erk in vivo in follicular (2013) (0)
CLINICAL CLASSIFICATION OF TUMORS (1982) (0)

This paper list is powered by the following services:

Other Resources About Elaine Jaffe

What Schools Are Affiliated With Elaine Jaffe?

Elaine Jaffe is affiliated with the following schools:

Elaine Jaffe's Academic­Influence.com Rankings